##### Table of Contents

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.



---



FORM 10-KSB



---



|x | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ------------------------------------------------------------------------------------



For the fiscal year ended June 30, 2004



| ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934
|- | -------------------------------------------------------------------------------



Commission File Number 0-29746



---



INNOVA PURE WATER, INC.

(Exact name of registrant as specified in charter)



---



|                                                               |  |                                  
|-------------------------------------------------------------- |  | ---------------------------------
|Florida                                                        |  | 59-2567034                       
|(State or other jurisdiction of incorporation or organization) |  | (IRS Employer Identification No.)
|                                                               | 
|13130  56thCourt, Suite 609, Clearwater,
Florida              |  | 33760                            
|(Address of principal executive offices)                       |  | (Zip code)                       



Registrants
telephone number, including area code: (727) 572-1000



---



Securities registered pursuant to Section 12(b) of the Exchange Act: None



Securities registered pursuant to Section 12(g) of the Exchange Act, Common
Stock, par value $.0001



---



Check whether the issuer (1) filed all reports required to be filed by section 13 or 15(d) of the Exchange Act during the past 12 months (or such shorter
period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    x  Yes ̈No



Check if no disclosure of delinquent filers in response to Item 405 of Regulation S-B is contained in this form, and no disclosure will be contained, to
the best of registrants knowledge, in definitive proxy of information statements incorporated by reference in Part III of this Form 10-KSB or any amendment to this Form 10-KSB  x



State issuers revenues for its most recent reporting period June 30,
2004 $671,300



Aggregate market value of the voting stock held
by non-affiliates of the registrant at June 30, 2004 was $496,944.



The number of shares of the Issuers Common Stock, par value $.0001 outstanding as of June 30, 2004 was 12,423,601



Transitional Small Business Disclosure Format ̈Yes    x  No



13130- 56thCourt, Suite
609, Clearwater, Florida 33760

(Former name or former address, if changed since last report)



---



---

##### Table of Contents

INNOVA PURE WATER, INC.

FORM 10-KSB - INDEX



|         |  |                                                                                                |  |   
|-------- |  | ---------------------------------------------------------------------------------------------- |  | --
|         | 
|Part I   |  |                                                                                               
|         |  |                                                                                               
|Item 1.  |  | Description of Business                                                                        |  | 3 
|         |  |                                                                                               
|Item 2.  |  | Description of Property                                                                        |  | 9 
|         |  |                                                                                               
|Item 3.  |  | Legal Proceedings                                                                              |  | 10
|         |  |                                                                                               
|Item 4.  |  | Submission of Matters to a Vote of Security Holders                                            |  | 10
|         | 
|Part II  |  |                                                                                               
|         |  |                                                                                               
|Item 5.  |  | Market for Common Equity and Related Stockholder Matters                                       |  | 10
|         |  |                                                                                               
|Item 6.  |  | Managements Discussion and Analysis of Financial Condition and Results of Operations          |  | 12
|         |  |                                                                                               
|Item 7.  |  | Financial Statements                                                                           |  | 17
|         |  |                                                                                               
|Item 8.  |  | Changes in and Disagreements with Accountants on Accounting and Financial Disclosures          |  | 17
|         |  |                                                                                               
|Item 8A. |  | Controls and Procedures                                                                        |  | 17
|         | 
|Part III |  |                                                                                               
|         |  |                                                                                               
|Item 9.  |  | Directors and Executive Officers of the Registrant                                             |  | 17
|         |  |                                                                                               
|Item 10. |  | Executive Compensation                                                                         |  | 19
|         |  |                                                                                               
|Item 11. |  | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |  | 25
|         |  |                                                                                               
|Item 12. |  | Certain Relationships and Related Transactions                                                 |  | 26
|         |  |                                                                                               
|Item 13. |  | Exhibits, Lists and Reports on Form 8-K                                                        |  | 27
|         |  |                                                                                               
|Item 14. |  | Principal Accountant Fees and Services                                                         |  | 28
|         |  |                                                                                               
|         |  | Signatures                                                                                     |  | 29
|         |  |                                                                                               
|         |  | Certifications                                                                                 |  |   



2



---

##### Table of Contents

INNOVA PURE WATER, INC.



This Annual Report on Form 10-KSB and the documents incorporated herein by reference contain forward-looking statements that have been made
pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations, estimates and projections about Innova Pure Waters industry, management beliefs, and
assumptions made by management. Words such as anticipates, expects, intends, plans, believes, seeks, estimates, variations of such words and similar expressions are
intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict; therefore, actual results and outcomes may
differ materially from what is expressed or forecasted in any such forward-looking statements.



PART I



ITEM 1. DESCRIPTION OF BUSINESS



Innova Pure Water, Inc. a Florida corporation (the Company we, us or Innova) was incorporated August 13, 1985. We design, develop, manufacture, and market unique consumer water filtration and
treatment products. These products have been historically of the portable nature and generally consist of a container serving as a water reservoir incorporating highly efficient water filtering and treatment technology. We have expanded into
multipurpose filtration products, including biological water treatment.



We hold in excess of 40 patents, issued or pending, directly associated with water treatment and purification which provide us with competitive advantages. It has been our ability to create both new products and develop technology that has
permitted Innova to differentiate ourselves from other competitors within the field and protect our product advantage. We have also demonstrated the ability to address and open significant new markets. Examples of these markets are portable personal
and sport type filter bottles for both mass markets desiring chemical, taste and odor removal, and outdoor markets where biological contaminant protection is a critical issue. Innova has attracted interest from large consumer products companies
enabling Innova to differentiate itself as a product innovator and creator and licensor as well as product producer, thus making us attractive as a strategic alliance partner to marketing and consumer product companies such as Sawyer Products,
CamelBak Products, and since December 2002 Innova has been supplying Nikken, Inc with their sport filter bottle products incorporating Nikkens exclusive PiMag additive and is in the process of proposing additional water treatment products for
Nikken. We are currently in various stages of discussion with other companies about possible strategic alliances.



Our water filtration products are designed to provide an improved quality and much better tasting water for the average consumer at an affordable price.
The Innova filtration process has been shown under independent taste tests to have no discernible taste or quality differences from the expensive premium priced bottled waters, while costing a fraction of the price. The products initially produced
by the Company were designed to treat tap water, reducing chlorine, lead, taste and odor. Within the past three years the emphasis has shifted to products which also remove bacteria and protozoea while retaining the capability for the removal of
specific chemical contents. Innova is presently in the development stages of larger appliance type products for the discerning consumer.



3



---

##### Table of Contents

We have developed filtration products for the removal of biological contaminants including protozoa,
cysts, and bacteria. A separate new product to disinfect water, which eliminates viruses, has been under review by the EPA. Products of this nature satisfy the needs of the outdoor, emergency, and international markets requiring highly effective
products for the treatment of biologically contaminated water. The company has or is introducing both portable and fixed products in the biological category. Other future products under development continue to include a Carafe and specialty
filter bottle products along with in-home appliance type products. Although Innova has very high expectations regarding the introduction of new products, there is no guarantee that these products will be fully developed or make it into the market
place. All products developed by Innova are created to meet world market requirements as well as the needs of the U.S. domestic market. If these products make it to market, there is no assurance that the Company will be able to commercially exploit
its water purification technologies on a profitable basis.



We
believe that as a result of the diminishing quality of tap water, both domestically and world wide, the opportunities for the application of our water filtration products and technology will continue to grow for a number of years. The water filter
market continues to grow reflecting consumer need for effective and efficient portable filtration devices. It is managements opinion that there will be substantial growth in sales in the water filtration product category, both domestically and
internationally. The water treatment industry remains in the developing stage with major growth still to come, both domestically and internationally.



It has been found that to a significant number of the consumers, drinking tap water has become both distasteful and suspect as a result of the use of
chlorine, which forms carcinogenic by-products and is strongly suspected by some members of the medical community to be a cause of arterial and heart disease. In addition, the dangers and frequency of heavy metals such as lead in tap water, as well
as the infrequent yet real potential for the presence of pathogenic biological contamination have made the consumer aware of the potential dangers associated with drinking tap water. The typical consumer of the Companys products primarily
seeks clean, fresh tasting water. Lead, in water, has become a well publicized and serious health concern to a large percentage of the populace, especially to mothers concerned for the health of their children. It has also been known that bacteria
contaminated private wells are pervasive and the source and cause of illness both domestically and worldwide



The retail customer base for our products consists of mass merchandisers, outdoor retailers, sporting goods stores as well as a wide range of markets
seeking products eliminating biological contaminants from naturally occurring surface water. This also constitutes the basic domestic market universe of strategic alliance partners that typically have wide distribution in retail stores and the
outdoor and international traveler markets. While there is no assurance that Innovas products will be purchased by retail customers, we hope to be a substantial participant in the alternative to bottled drinking water market as the market for
water treatment products increase.



In order to overcome the
disadvantage of being a small company, and lack of capital to adequately support a national sales program, our strategy has been and remains to create strategic alliances with nationally recognized companies. As a result, we obtain the distribution
and sales of its products on a national and international basis without incurring the sales and marketing costs usually associated with the sales of consumer products. The Company also benefits by the consumer acceptance of the brand names and the
reputation of the strategic alliance partners such as Sawyer Products in the camping and outdoor markets; and CamelBak Products in a wide variety of retail stores, catalogs, and the military with their hydration products and Nikken with direct to
the consumer distribution domestically and internationally.



4



---

##### Table of Contents

In addition to the sales of products either directly or through strategic alliance partners, Innova is
willing to license competitive companies allowing them to sell into the market in return for financial remuneration. In this regard, Innova has licensed Brita Products and Seychelle Environmental to produce and market specific products under
license. Sawyer Products has been licensed to market under specific patents. To date, with acceptance of Sawyer, license fees have not been a material source of revenues.



During the fiscal year ended June 30, 2003, shipments of the Companys filtration products to CamelBak, Nikken, Inc.
and Sawyer Products comprised the majority of the Companys total sales for the fiscal year comprising 20%, 42% and 25%, respectively. For the fiscal year ended June 30, 2004, shipments to Sawyer Products and Nikken, Inc. comprised the majority
of sales for the year, comprising 55% and 40%, respectively.



In connection with the Licensing, Product Supply and Strategic Alliance Agreement entered into with CamelBak on July 15, 2002, we granted CamelBak a worldwide exclusive license to market and distribute Innova in-line biological-chemical
filters for use with hydration packs to the military and after markets currently serviced by CamelBak specifically excluding Japan and France. The initial order from CamelBak was for 10,000 filtration units. CamelBak paid us an exclusive initial
distribution fee of $50,000. The exclusivity of this license expires in July of 2004 as a result of CamelBaks failure to meet their purchasing requirements. As a result, Innova will seek additional lines of distribution for this product.



Innova continues to search for major multinational companies
for distribution into the international markets. To date, distribution into international markets has not yet developed into what management hopes will be substantial and consistent sales.



CURRENT PRODUCTS



We currently produce products for distribution and sales through our strategic alliance partners, as well as directly to
select classes of trade on both a domestic and international basis. All products currently marketed are patent protected under one or more issued or pending patents. Additional patents are also pending. See Business-Intellectual
Property. We currently offer the following products:



| | 1. | A 16 oz. standard 28 mm neck PET water bottle with replaceable filter, A Filter and a push-pull valve cap;
| | -- | ------------------------------------------------------------------------------------------------------------



| | 2. | A 16 oz. LDPE sport type bottle with B Filter with a push-pull valve cap.
| | -- | ---------------------------------------------------------------------------



| | 3. | A 27 oz. LDPE sport type bottle with a B Filter with a push-pull valve cap.
| | -- | -----------------------------------------------------------------------------



| | 4. | Replacement filters A, B chlorine removal, and B lead and chlorine removal for installation into Sawyer, Avon, Culligan, and Innova WaterWay® sport type bottles.
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 5. | A dual filter biological and chlorine/lead removal sport type bottle.
| | -- | ---------------------------------------------------------------------



| | 6. | An in-line combination bacteria/protozoa and chlorine/lead removal filter for hydration packs and container-to-container filtration and water treatment applications.
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 7. | And selected products produced exclusively for Nikken and Sawyer Products.
| | -- | --------------------------------------------------------------------------



Innova has been successful in improving the functionality and contaminant removal capability of its standard A and B filters used
in the sport and personal line of water filter bottles. Both filters now remove over 90% of chlorine when new and remain above the 75% minimum required over 20 gallons for certification by NSF International. Both also remove over 90% of lead at a
flow of 10ml/sec over the suggested 20 gallon life of the product. No competitive product contains this capacity for lead removal nor can equal the Innova filters for certified chlorine removal capability.



5



---

##### Table of Contents

We manufacture and assemble our current product line in Clearwater, Florida. We also utilize several
component vendors and contract manufacturers. As a result of the vendor relationships established over the years, management believes we have reliable and available capacity to sustain the production of the current product lines. We have
investigated possible overseas suppliers and may use overseas assembly and overseas manufacturing sources in the future. Although the Company expects an advantage in manufacturing costs from overseas relationships, there is no assurance that these
relationships will be sufficiently tractable for the Companys needs; further, there is no assurance that such vendor relationships will continue in a successful manner.



PRODUCT DEVELOPMENT



The Company has historically been actively engaged in new product development, and the application of new and emerging technology for products which will
increase our value to both strategic alliance partners and investors. It is the opinion of management that the technology and product concepts controlled by us can permit our strategic alliance partners to become, and remain, the dominant companies
in consumer water treatment. Products under development include improved highly flexible multi-purpose water filter bottle designs, biological treatments with expanded functionality, and our patented Static Filtration technologies.
Development pertaining to products that are classified in the appliance category have also been undertaken.



A prototype of the System type sports bottle has been completed and has generated interest. In the System approach, treatment
options are arranged radially rather than axially. This allows for higher performance and the ability to incorporate more treatment options. It remains to be seen if this product will be placed in production in the near future.



Efforts are ongoing to extend our biological treatments to cover waters which
suffer from viral contamination. Innova has entered into a marketing agreement with the producer of a highly effective chlorine tablet. To date, this product, has been submitted to the EPA for approval.



Development of high performance Static Filtration pitcher/bottle
products has been completed. The Company will place products using this technology into production once the distribution channels have been secured and the Company is prepared to place the product within its budget. Patents have been issued on
technical aspects including filter media manufacture. In Static Filtration, passive means are used to ensure that the residence times required for optimal treatment occur within the treatment vessels. Additional patent applications have
been filed.



Although we are attempting to improve the time to
market of our developmental efforts, there is no assurance that the Company will ever successfully bring these products to market.



During fiscal years ended June 30, 2004 and 2003, we spent $10,100 and $92,300, respectively, on research and product development. Unless we generate
significant sales or obtain additional capital we will not be able to sustain our research and development efforts.



SALES AND BACKLOG



The net sales for the fiscal year ended June 30, 2004 were $671,300. The net sales for the preceding fiscal year ending June 30, 2003 were $608,000. Gross
revenue for fiscal year ending June 30, 2004 was $805,900 as compared with gross revenue of $678,100 for the preceding year ended June 30, 2003.



6



---

##### Table of Contents

Delays in the completion and introduction of our second and third generation biological dual filter sport
bottles and the marketing dictates of packaging reduced the market penetration. For the developing appliance category of water treatment products, the need to supply highly demanding test data as produced and certified by NSF has delayed the
introduction of this class of product together with financial constraints.



As has been noted in Footnote 1 of the accompanying annual financial statements, 95% of the Companys sales were to Sawyer Products and Nikken for the fiscal year ended June 30, 2004. The loss of either of these
customers would have a materially adverse impact on our financial position.



COMPETITION



We compete with many other
companies that supply water filtration products. The principal competitors non-biological product is the pour through carafe type product normally kept in the refrigerator and used in the kitchen. Several companies, including
Brita, Procter & Gamble (Pûr), Culligan and others compete in the pitcher or carafe products market segment. The leading company in the domestic pitcher category within the last twelve months is Clorox, selling the Brita line.



The introduction of our biological product line brings us into direct
competition with products making similar claims, which are marketed by Extreme and Safe Water Anywhere. We commissioned a study by an independent laboratory located at the University of South Florida whose test results have shown our product to
provide superior performance under actual use conditions. Products pressurized by pump pressure and marketed by Katadyne and Mountain Safety Research are also competitive in performance while considerably more expensive. The Innova Biological
product was tested by Spectrum Laboratories, an EPA recognized independent testing laboratory, which when subjected to the full EPA protocol provided the required minimum six log reduction (99.9999%), or better. We know of no other similar product
that has passed this test.



We also compete indirectly with
other companies that supply bottled water, including The Perrier Group of America, Inc. (Dasani, Aquifina, Arrowhead Mountain Spring Water, Poland Spring, Ozarka Spring Water, Zephyrhills Natural Spring Water, Deer Park, Great Bear and Mountain Ice)
and Great Brands of Europe (Evian Natural Spring Water and Dannon Natural Spring Water). The Company also competes with numerous regional bottle water companies located in the United States and Canada.



We were the early leader in sales of portable bike, sport, and 16-oz.
personal filter water bottles, all of which are covered by patents held by us. The category remains relatively new with the majority of growth expected by the Company over the next several years. The Innova portable personal water filter bottles
were initially introduced by Richard Simmons under contract with GoodTimes Licensing and Entertainment. In the first year over 2,000,000 16-oz. personal water filter bottles and thousands of 30 oz. sport type bottles were sold.



Since then, Brita Products and others have entered this expanding new market
category. The Companys position in this market has been vigorously defended against competition attempting to enter this market. Innova has prevailed in litigation, protecting its patent position even against market leaders such as Brita. The
strength of our intellectual property has caused most companies with potentially infringing products to withdraw from this market. However,



7



---

##### Table of Contents

many of the companies with whom we currently compete, or may compete in the future, have greater financial, technical,
marketing, and sales resources, as well as greater name recognition than us. There can be no assurance that we will have the resources required to respond effectively to market or technological changes or to compete successfully in the future,
although our existing and pending alliances provide certain advantages in these regards as does our patent position.



INTELLECTUAL PROPERTY



We have a strong intellectual property position. This position includes rights to numerous patents in the consumer product water treatment field with over
40 issued or pending patents which are specifically related to consumer water treatment products. . The patents and related rights were assigned to the Company from Mr. Nohren and other employees.



On July 30, 1999, Innova brought an action for infringement of Innova patent
#5,609,759 against Safari Water Filtration Systems, Inc. d/b/a Safari Outdoor Products of Broom Field, Colorado. Innova filed for summary judgment and the Court found in behalf of Safari, subsequently, Innova immediately filed an appeal in the
Federal Court of Appeals as case 04-1097. On August 11, 2004 the Court of Appeals overturned the lower courts decision and returned the case to the lower court. Innova has again filed for summary judgment and currently, the case remains
pending in Tampa Federal Court, Case No.99-1781-CIV-T-23F. See Description of Business  Litigation.



On January 24, 2000, Innova brought a patent infringement suit against the Brita Products Company of Oakland, California. On February 26, 2001, this case
was settled to the Companys satisfaction and the Company is currently receiving quarterly royalty payments from Brita Products resulting from the final disposition of the suit. A non-disclosure agreement is in place in regard to this
settlement.



MANUFACTURING



Operations are centered in our facility in Clearwater, Florida, where
historically the quality assurance, inspection, testing, assembly, packaging and shipping functions have been performed. Our products consist principally of: (1) one or more elements containing water treatment media or devices; and (2) injection
molded plastic components, blow molded or injection molded containers which hold the water to be processed as well as to support and position the water filtration element. In addition, labels, bags, and a variety of boxes are also used to package
various products. The filtration media consist of proprietary monolithic filter elements containing activated carbon with a plastic binder and one or more other compounds depending upon the use to which the filter is to be applied. The media
elements are obtained from a variety of sources. Typically, each is procured under the terms of a confidentiality agreement and to our specifications.



We have a domestic filter element production capacity of over 9,000,000 units per year. This capacity may be increased should demand increase beyond the
existing capacity. Two or more suppliers are available for most components. By so doing we have established a close working relationship with competent suppliers to assure price and quality competition and sufficient capacity to meet current and
future requirements. Injection and bottle molds are owned or managed by Innova. Even so there is no assurance, that competitive pricing and production capacity will be available in the future.



8



---

##### Table of Contents

Presently, one company supplies the blow-molded components. A second Company supplies the majority of our
injection molded components. Typically, we own the tooling to produce the blow and injection molded components.



Several years ago we changed from principally manual assembly and packaging operations to partially mechanized operations. These operations include
assembling; (1) the media elements into the housings; (2) the closure to the filter housings; (3) the top and valve components together; and (4)the semi-automatic assembly of certain filters into hermetically sealed bags, and (5) automatic labeling
of the bottles, as appropriate.



We possess considerable
in-house manufacturing know-how. The expertise spans from tool and mold design to automated dispensing and compacting of media, through inspection, assembly, and packaging. As such we act in an advisory capacity with many of our vendors, or specify
the methodology to be used. This internal capability also keeps us from becoming a hostage to any supplier and permits us to make justified make or buy decisions based upon the true economic impact. This permits the Company
to purchase high quality components at a competitive price while remaining independent.



All vendors operate under confidentiality agreements. Several organizations also support the Company in its product development program on an as needed basis. The Company has relied on a limited number of vendors to
supply the components necessary for its products. A lack of necessary components at favorable prices would adversely affect us.



PRODUCT LIABILITY INSURANCE AND WARRANTIES



We maintain a $1,000,000 product liability insurance policy and a $2,000,000 umbrella excess liability policy. In the eighteen years in which we have
produced and furnished products to the retail trade and consumers, both domestically and internationally, no product suits have been filed, nor consumer complaints received, which would lead to litigation.



We warrant to our strategic alliance partners that the products will be
produced to mutually agreeable standards. Innova operates a formal quality control program monitoring through Acceptable/Acceptance Quality Level (AQL) standards, incoming components, in process parts, and completed units. Detail product
specification sheets are in place as well as Physical Proofs which have been signed off and accepted by both parties. In case of a question, the Proof samples are used for comparison purposes to determine acceptability.



EMPLOYEES



As of June 30, 2004, we had four full-time employees and one part time
employees. This includes its two executive officers, one administrative and clerical person, one vice president who is our manufacturing manager, and one part-time person who provides accounting support. The manufacturing and manager is supplemented
by as many as 15 contract employees, as required.



ITEM 2. DESCRIPTION OF PROPERTY



We occupy approximately 6,400 feet of air-conditioned office, manufacturing and warehouse space located at 13130  56thCourt, Suite 607-610, Clearwater, Florida 33760. The product development laboratory is also located in the building. The facilities are leased and a new one-year lease commenced April 1, 2004. The monthly rent payment for these
facilities is approximately $3,500.



9



---

##### Table of Contents

ITEM 3. LEGAL PROCEEDINGS



Innova
brought an action for infringement of Innova patent #5,609,759, Safari Water Filtration Systems, Inc. d/b/a Safari Outdoor Products of Broom Field, Colorado. This case was filed in Tampa Federal Court, Case No.99-1781-CIV-T-23A on August 4, 1999.
The Company has claimed patent infringement of U.S. Patent 5,609,759 on the part of the defendants. Management believes we have a strong case, especially in light of the favorable outcome of the Brita, Aladdin and Seychelle patent infringement
cases. Innova filed for summary judgment and the court ruled in favor of Safari on December 16, 2003. Innova immediately filed an appeal with the United States Court of Appeals, case 04-1097, and on August 11, 2004, the Appeals Court reversed the
lower courts decision. The case was remanded back to the Circuit Court on September 1, 2004 to find on any remaining issues. Innova has filed for summary judgment or the prompt setting of a trial date. On September 16, 2004, Safaris
attorney withdrew as counsel and requested a thirty day extension to respond to Innovas request.



On January 24, 2000, Innova brought a patent infringement suit against the Brita Products Company of Oakland California. This case was pending in Tampa,
Fl. Case No.8:00-157-CV-T23A claiming infringement of Innova patent #5,609,759. In the Brita suite Innova sought treble damages believing the infringement was willful. On February 26, 2001, the Company and Brita reached a settlement agreement on
terms management feels are favorable to the Company, which includes quarterly royalty payments.



Previously, patent infringement suits were instituted by Innova in which Innova prevailed. These separate suits were vs. Aladdin Sales and Marketing and
vs. Seychelle Environmental; both of which were settled to Innovas satisfaction. Aladdin is paying damages and exiting the market and Seychelle has entered into a license agreement with Innova.



ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS



None.



PART II



ITEM 5. MARKET PRICE OF THE REGISTRANTS SECURITIES AND RELATED STOCKHOLDER MATTERS



Our Common Stock is traded in the over-the-counter market in the so called pink sheets, or on the Electronic Bulletin Board of the
National Association of Securities Dealers, Inc. (the NASD) under the symbol IPUR. The transfer agent and registrar for the Common Stock is Continental Stock Transfer & Trust Company of New York. The following table sets
forth, for the periods indicated, the high and low sales price for shares of the Common Stock as reported on the OTC.



|                                |  |             |  |      
|------------------------------- |  | ----------- |  | -----
|                                |  | Sales Price
|                                |  | High        |  | Low  
|FISCAL YEAR ENDED JUNE 30, 2004 |  |             |  |      
|Fourth Quarter                  |  | 0.080       |  | 0.040
|Third Quarter                   |  | 0.070       |  | 0.040
|Second Quarter                  |  | 0.100       |  | 0.060
|First Quarter                   |  | 0.140       |  | 0.080
|                                |  |            
|FISCAL YEAR ENDED JUNE 30, 2003 |  |             |  |      
|Fourth Quarter                  |  | 0.140       |  | 0.050
|Third Quarter                   |  | 0.090       |  | 0.050
|Second Quarter                  |  | 0.130       |  | 0.050
|First Quarter                   |  | 0.280       |  | 0.060



10



---

##### Table of Contents

Our Common Stock is not listed on NASDAQ, but is traded in the over-the-counter market on the
Electronic Bulletin Board of the National Association of Securities Dealers, Inc. (the NASD). Accordingly, an investor may find it more difficult to dispose of, or obtain accurate quotations as to the market value of the
common stock. Further, in the absence of a security being quoted on NASDAQ, a market price of at least $5.00 per share or the Company having in excess of $2,000,000 in net tangible assets, trading in the Companys securities may be covered by a
Securities and Exchange Commission (SEC) rule that imposes additional sales practice requirements on broker-dealers who sell such securities to persons other than established customers and accredited investors (generally institutions
with net worth in excess of $1,000,000 or annual income exceeding $200,000 or $300,000 jointly with their spouse). For transactions covered by the rule, the broker-dealer must make a special suitability determination for the purchaser and receive
the purchasers written agreement to the transaction prior to the sale. Consequently, the rule affects the ability of broker-dealers to sell the Companys securities and also may affect the ability of shareholders to sell their securities
in the secondary market.



Previously, the SEC adopted seven
rules (Rules) under the Securities Exchange Act of 1934 requiring broker/dealers engaging in certain recommended transactions with their customers in specified equity securities falling within the definition of penny stock
(generally non-NASDAQ securities priced below $5.00 per share) to provide to those customers certain specified information. Unless the transaction is exempt under the Rules, broker/dealers effecting customer transactions in such defined penny stocks
are required to provide their customers with: (1) a risk disclosure document; (2) disclosure of current bid and ask quotations, if any; (3) disclosure of the compensation of the broker/dealers and its sales person in the transaction; and (4) monthly
account statements showing the market value of each penny stock held in the customers account.



As a result of the aforesaid rules regulating penny stocks, the market liquidity for our securities could be severely adversely affected by limiting the
ability of broker-dealers to sell our securities and the ability of shareholders to sell their securities in the secondary market



Recent SEC and NASD revisions and interpretations of Rule 15c2-11 require us to maintain our status as a reporting company under Section 12(q) of the
Securities Exchange Act of 1934. Our failure to timely file annual, quarterly or other reports may affect our ability to maintain listing in the OTC Electronic Bulletin Board.



We have not paid any cash dividends on our common or preferred stock and do not anticipate paying any such cash dividends in
the foreseeable future. Earnings, if any, will be retained to finance future growth. We may issue shares of our common stock and preferred stock in private or public offerings to obtain financing, capital or to acquire other businesses that can
improve our performance and growth. Issuance and or sales of substantial amounts of common stock could adversely affect prevailing market prices in our common stock.



As of June 30, 2004 and there were approximately 400 beneficial owners of our common stock with 12,449,684 shares issued and
12,423,601 shares outstanding.



11



---

##### Table of Contents

ITEM 6. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS



IMPORTANT NOTE ABOUT FORWARD-LOOKING STATEMENTS



The following discussion and analysis should be read in conjunction with our audited financial statements as of June 30, 2004 and the notes thereto, all
of which financial statements are included elsewhere in this form 10-KSB. In addition to historical information, the following discussion and other parts of this Form 10-KSB contain forward-looking information that involves risks and uncertainties.
Our actual results could differ materially from those anticipated by such forward-looking information due to factors discussed under Business and elsewhere in this Form 10-KSB.



The statements that are not historical constitute forward-looking
statements. Said forward-looking statements involve risks and uncertainties that may cause the actual results, performance or achievements of Innova to be materially different from any future results, performance or achievements, express or
implied by such forward-looking statements. These forward-looking statements are identified by their use of such terms and phrases as expects, intends, goals, estimates, projects,
plans, anticipates, should, future, believes, and scheduled.



The variables which may cause differences include, but are not limited to, the following: general economic and business conditions; competition; success
of operating initiatives; ability to protect our patents and intellectual property; success of our joint venture and strategic alliance efforts; market acceptance of our water purification products; operating costs; advertising and promotional
efforts; the existence or absence of adverse publicity; changes in business strategy or development plans; the ability to retain management; availability, terms and deployment of capital; business abilities and judgment of personnel; availability of
qualified personnel; labor and employment benefit costs; availability and costs of raw materials and supplies; and changes in, or failure to comply with various government regulations. Although the Company believes that the assumptions underlying
the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this Form 10-KSB will prove to be accurate.



In light of the significant uncertainties inherent in the
forward-looking statements included herein the inclusion of such information should not be regarded as a representation by the Company or any person that the objectives and expectations of the Company will be achieved.



SELECTED FINANCIAL DATA



The following financial data is derived from and should be read in conjunction with the Consolidated Financial
Statements and notes thereto. Information concerning significant trends in the financial condition and results of operations is contained in Managements Discussion and Analysis of Financial Condition and Results of Operations.



SELECTED SUMMARY INCOME STATEMENT DATA



|                                          |  |                    |            |   |      |   |            |  
|----------------------------------------- |  | ------------------ | ---------- | - | ---- | - | ---------- | -
|                                          |  | Year Ended June 30 |           
|                                          |  | 2004               |            |   | 2003 |  
|Total sales revenue                       |  | $                  | 671,300    |   |      | $ | 608,000    |  
|Net loss                                  |  | $                  | (282,800   | ) |      | $ | (579,900   | )
|Loss per common share  basic             |  | $                  | (.02       | ) |      | $ | (.05       | )
|Shares used in per share computation      |  |                    | 12,182,781 |   |      |   | 11,129,290 |  
|Loss per common share  assuming dilution |  | $                  | (.02       | ) |      | $ | (.05       | )
|Shares used in diluted computation        |  |                    | 12,182,781 |   |      |   | 11,129,290 |  



12



---

##### Table of Contents

SELECTED SUMMARY BALANCE SHEET DATA



|                        |  |              |          |  
|----------------------- |  | ------------ | -------- | -
|                        |  | June 30,2004 |         
|Total assets            |  | $            | 360,900  |  
|Working capital deficit |  | $            | (444,500 | )
|Long-term debt          |  | $            | 164,400  |  
|Stockholders deficit   |  | $            | (608,900 | )



CRITICAL ACCOUNTING POLICIES AND
ESTIMATES



The following discussion and analysis is based
upon our financial statements, which have been prepared in accordance with accounting principles general accepted in the United States of America. The preparation of our financial statements requires management to make estimates and assumptions that
affect the reported amounts of revenues and expenses, and assets and liabilities during the periods reported. Estimates are used when accounting for certain items such as revenues, allowances for returns, doubtful accounts, employee compensation
programs, depreciation and amortization periods, taxes, inventory values, insurance programs, goodwill, other intangible assets and long-lived assets. We base our estimates on historical experience, where applicable and other assumptions that we
believe are reasonable under the circumstances. Actual results may differ from our estimates under different assumptions or conditions.



We believe that the following critical policies affect our more significant judgments and estimates used in preparation of our consolidated financial
statements. We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. We base our estimates on the aging of our accounts receivable balances and our historical
write-off experience, net of recoveries. If the financial condition of our customers were to deteriorate, additional allowances may be required.



We value our inventories at the lower of cost or market. We write down inventory balances for estimated obsolescence or unmarketable inventory equal to
the difference between the cost of the inventory and the estimated market value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory
write-downs may be required.



We amortize patent application
costs, which includes litigation defense costs over a five (5) year period. As noted under the Section Executive Compensation-Options we have changed the accounting treatment for a no interest loan and related options to reflect the
value of such options as interest expense.



See also Footnote 3
 Significant Accounting Policies in the Financial Statement.



RESULTS
OF OPERATIONS



Net Sales



Net sales for the twelve-month period ended June 30, 2004 were $671,300, an
increase of 10 percent from the $608,000 of net sales for the comparable period in 2003. This increase was due to increased sales to trading partners Sawyer Products and Nikken Global. For the fiscal year ended June 30, 2004, shipments to Sawyer
Products and Nikken, Inc. amounted to 55% and 40% of sales, respectively.



13



---

##### Table of Contents

Cost of Sales



For the year ended June 30, 2004, the cost of sales increased to $396,500 from the $343,400 of cost of sales for the year ended June 30, 2003. This
increase is mainly due to the increase in sales.



Gross profit
margin decreased 3 percent for the year ended June 30, 2004, to 41 percent from an overall gross profit margin of 44 percent for the year ended June 30, 2003.



Operating Expense



Operating expenses for the year ended June 30, 2004 were $660,400, or 98 percent of net sales. For the comparable period in 2003, operating costs amounted
to $858,100, or 141 percent of net sales. The decrease in operating expenses is principally due to a reduction in non-essential expenditures. Also, we reduced the amount of expenditures for research and development.



Other Income and Expense



For the year ended June 30, 2004, net interest expense amounted to $31,800
as compared to net interest expense of $56,500 for the year ended June 30, 2003. This change is due to the interest on a note payable during the year ended June 30, 2003 and the Company recording $45,000 as interest expense through the amortization
of the discount on the $400,000 note payable. The discount on the note payable originated through a reconsideration of the relationship between an individual receiving options for marketing services and the relationship between the entity that
advanced us the $400,000. Originally the individual was treated as an employee and no imputed expense was recognized. Upon closer review, Innova recognized the relationship between this individual and the entity that advanced us the $400,000
interest free loan. Accordingly, the fair market value of these options is treated as a discount.



Royalty income for the year ended June 30, 2004 of $21,800 was due to royalties received from Brita Products for the licensing of the Companys
technology. Royalty income for the year ended June 30, 2003 of $45,100 was also due to the licensing of the Companys technology to Brita Products and Seychelle Environmental. The increase in royalty income is due to the new agreement with
Sawyer Products that began in fiscal year ended June 30, 2004.



Other income for the year ended June 30, 2004 and 2003 of $112,800 and $25,000, respectively, realized revenue for the from the exclusive licensing agreement payments received from CamelBak and Sawyer Products.



Income Taxes



Due to the Companys history of operating losses, management has established a valuation allowance in the full amount
of the deferred tax assets arising from these losses, as management believes it is more likely than not that the Company will not generate sufficient taxable income within the appropriate period to offset these operating loss carry forwards.



14



---

##### Table of Contents

Net Loss



Net loss for the year ended June 30, 2004 amounted to $282,800, as compared to net loss of $579,900 for the comparable period in 2003. The decrease in net
loss is primarily a result of the increase in sales and the cost cutting measures implemented by management.



Loss Per Share



For the
year ended June 30, 2004, basic and diluted loss per share amounted to $(.02). For the comparable period in 2003, basic and diluted loss per share amounted to $(.05). The decrease in loss per share is due to the decrease in net loss between the
comparable periods.



LIQUIDITY AND CAPITAL RESOURCES



Operating Activities



For the year ended June 30, 2004, net cash provided by operating activities amounted to $5,000, as compared to the $33,800
provided by operating activities for the comparable period in 2003. This change is primarily due to the decrease in accounts and other receivables as of June 30, 2004.



Investment Activities



The Companys investment activities include equipment sales and purchases, patent acquisition and defense and receipt of restricted cash.



Net cash used by investing activities for the year ended June 30, 2004 was
approximately $67,400, as compared to net cash used by investing activities of approximately $27,500 for the comparable period in 2003. The decrease in cash expended for investing activities is due primarily to a decrease in expenditures on new
equipment and the receipt of cash during the year ended 2004 to be used for a specified purpose.



Financing Activities



The Company provided $13,600 of financing activities for the year ended June 30, 2004, as compared to no financing activities for the year ended June 30, 2003. This change resulted primarily from the bank overdraft.



During the year ended, June 30, 2003, the Company recognized that the
issuance of 1,200,000 options was partially based upon the relationship between the individual and the entity that advanced the Company $400,000 on an interest-free loan and will no longer consider the individual an employee. Therefore, the Company
treated the fair value of these options, $180,000, as prepaid interest and is amortizing them over the term of the note.



As shown in the accompanying financial statements, we incurred a net loss of $282,800 during the year ended June 30, 2004 and as of that date; our current
liabilities exceeded our current assets by $670,700. Therefore, our ability to continue as a going concern is uncertain. We expect to incur significant losses in the future. As a result, we will need to generate significant revenues to achieve
profitability and may never achieve profitability.



Although we
continue to maintain our efforts to conserve cash, such efforts will not make us a viable business entity, and without significant additional revenues we may not be able to stay in business. Our two executive officers have agreed to defer a
substantial portion of their compensation and payments.



15



---

##### Table of Contents

We continue to explore the possibility of outsourcing some of our production and support tasks that are
currently being done in-house in order to reduce such costs. However, until we have sufficient volume to support significant outsourcing, we are not in a position to outsource production to save costs.



We have not been successful in attracting outside capital. Although we
continue to pursue various opportunities, we cannot assure you that we would be able to raise any outside capital or that such funds will be available to us on favorable terms. If we raise additional funds through the issuance of our equity or debt
securities, such securities may have rights, preferences or privileges senior to those of the rights of our common stock and our stockholders may experience substantial dilution.



As of June 30, 2004, we had past due invoices totaling approximately $36,400 with our major bottle supplier and molded parts
supplier. Each of these suppliers have agreed to accept minimum weekly payments of $1,000 (minimum of $8,000 collectively per month) to satisfy these unpaid obligations. To date we have not experienced any difficulty in securing the necessary raw
materials from these or other vendors. However, if we fail to maintain these weekly payments or if our vendors require satisfaction of outstanding obligations to fulfill new orders our operations could be adversely affected.



We are in continuous discussions with new prospective strategic alliance
partners. Unfortunately, we have not secured any new significant strategic alliances in fiscal 2004 and there is no assurance we will enter into any new alliances in fiscal 2005. To date, our arrangements with CamelBak, Sawyer Products and Nikken
have not generated significant revenues and it does not appear these alliances will result in significant revenues for fiscal 2005. We continue to have discussions with other businesses regarding merging a private company into Innova that has a
complimentary business or product lines. We have not been able to finalize the terms of any proposed acquisitions. We will continue to explore this possibility in fiscal 2005.



Our principal capital and liquidity needs historical have related to the acquisition, procurement and manufacturing of
component parts relating to our water filtration products, sales and marketing activities, the development of manufacturing infrastructure, litigation costs associated with patent protection, and compensation to our executive officers. Because we
have not had sufficient capital resources, we may have to substantially scale back research and development efforts, marketing and improvement of our manufacturing infrastructure. Unfortunately, we do not believe that we are in position to
substantially decrease our capital and liquidity requirements through additional cost cutting efforts. Thus, there is no assurance that we will be able to stay in business. If we are not able to attract additional capital or generate significant
revenues through our existing or new strategic alliances, it does not make sense for us to continue our status as a reporting issuer under Section 12(g) of the Securities Exchange Act of 1934, as amended. As such, management may be required to
deregister in fiscal year ending June 30, 2005 as it will be unable to absorb and pay for the costs of maintaining its status as a reporting issuer under the 1934 Act.



INFLATION



We believe that the impact of inflation and changing prices on our operations since the commencement of our operations has been negligible.



16



---

##### Table of Contents

SEASONALITY



Innova does not deem its revenues to be seasonal.



ITEM 7. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA



The information required by this item is presented at page F-1.



ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURES



None.



ITEM 8A. CONTROLS AND PROCEDURES



Evaluation of disclosure controls and procedures.



Under the supervision and with the participation of our Management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operations of our disclosure
controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of June 30, 2004. Based on this evaluation, our principal executive officer and principal financial officer concluded that our
disclosure controls and procedures were effective such that the material information required to be included in our Securities and Exchange Commission (SEC) reports is recorded, processed, summarized and reported within the time periods
specified in SEC rules and forms relating to Innova Pure Water, Inc., including our consolidated subsidiaries, and was made known to them by others within those entities, particularly during the period when this report was being prepared.



PART III



ITEM 9. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT



DIRECTORS AND EXECUTIVE OFFICERS OF THE COMPANY



The following table sets forth certain information with respect to each person who is a director or an executive officer of the Company as of June 30, 2004.



|                    |  |     |  |                                             
|------------------- |  | --- |  | --------------------------------------------
|Name                |  | Age |  | Position                                    
|John E. Nohren, Jr. |  | 73  |  | Chairman of the Board, Director             
|Rose C. Smith       |  | 53  |  | President, Chief Executive Officer, Director
|Emanuel Mersis      |  | 60  |  | Interim Chief Financial Officer, Director   
|John T. Smith       |  | 48  |  | Vice President- Manufacturing               
|Peter Christensen   |  | 54  |  | Director                                    



Executive officers are
elected by the Board of Directors and serve until their successors are duly elected and qualify, subject to earlier removal by the Board of Directors. Directors are elected at the annual meeting of shareholders to serve for their term and until
their respective successors are duly elected and qualify, or until their earlier resignation, removal from office, or death. The remaining directors may fill any vacancy in the Board of Directors for an unexpired term. See Board of
Directors for a discussion of the Directors terms.



17



---

##### Table of Contents

BUSINESS EXPERIENCE OF EXECUTIVE OFFICERS AND DIRECTORS



John E. Nohren, Jr. has been Chairman of the Board of the Company since its
inception. During 1996, with Mr. Nohrens consent and approval, he resigned as President and Rose C. Smith was appointed his successor. He subsequently resigned as Chief Executive Officer in June of 1997 when Rose C. Smith was appointed his
successor. In June 1998, Mr. Nohren was elected Treasurer and interim Chief Financial Officer. He was also the founder and the major shareholder of a prior Company, Innova, Inc., founded in 1969 to service the increasing requirement of the U.S.
Department of Defense for sophisticated automation and hazardous waste management. With government funding, Mr. Nohren made technological advances for dealing with water contamination of various natures. The applications included the treatment of
water in a chemical, biological, or nuclear war scenario. The applications also dealt with the removal of a variety of contaminants from the production of military products. The obvious voids, and needs for the application of those technologies to
consumers lead to the formation of the Company in 1985. He is the named inventor on patents, which he has assigned to the Company.



Rose C. Smith was appointed President during 1996, and President and Chief Executive Officer effective June 30, 1997. Ms. Smith began her career in the
financial community at Bache and Co., Inc. (Prudential Securities, Inc.) and was a financial adviser to the principals of the Moore McCormick Shipping Lines. She functioned in a number of consulting roles relative to product acquisition, licensing,
and line extensions and has been retained by Aguecheek Ltd. in England, which owned the licensing rights to Armani, Valentino, Ungaro, Tiffany and others. Ms. Smith was also a consultant regarding potential corporate acquisitions for Marubeni in
Tokyo. She became associated with the Company in 1993 as a marketing consultant, hence became the Director of Business Development until elected President in 1996, and Chief Executive Officer in June 1997.



Emanuel Mersis has been a director of the Company since 2000 and began
serving as Interim CFO in the fiscal year ended June 30, 2004. Mr. Mersis has over 30 years experience in consumer packaged goods general management, finance, operations, marketing, sales, and acquisitions/divestitures. Mr. Mersis has held senior
management positions with Aqua Clara Bottling and Distribution, Inc., Westvaco Corporations Consumer Packaging Division, and Signature Brands LLC. Mr. Mersis has also served in senior sales and marketing positions with RJR Foods/Del Monte,
Alberto-Culver Company, and the Procter & Gamble Company.



John T. Smith, Vice President- Manufacturing, has been responsible for the Companys plant operations including manufacturing, distribution, and purchasing since he joined Innova in 1988. Prior to joining Innova, Mr. Smith was the
Production Manager for Nemco, and while there contributed significantly to their growth and development of their automated assembly production of consumer products.



Peter Christensen has been a director of the Company since June 1995. Since September 1997, he has been the Chief Executive
Officer of ComTech, Incorporated, a software company that provides integrated art print and mail services as well as art electronic imaging, E-mail delivery, and electronic payment services, integrated with credit card and personal financial
software. Since August 1995, Mr. Christensen has been a member of the board of Digital Privacy, Inc., a smart card based computer and communications security company, securing communications across the internet. Prior to joining ComTech,
Incorporated in 1997 he was a managing director at Paine Webber, for the period 1993 through 1997.



18



---

##### Table of Contents

BOARD OF DIRECTORS



The Companys Bylaws fix the size of the Board of Directors at no fewer than one and no more than nine members, to be elected annually by a plurality
of the votes cast by the holders of Common Stock, and to serve until the next annual meeting of stockholders and until their successors have been elected or until their earlier resignation or removal. During the fiscal year ended June 30, 2004,
Andrew Greenburg resigned due to other increased business obligation. We currently have four (4) directors, two (2) of which are outside directors.



A director who is an employee receives no additional compensation for services as director or for attendance at or participation in meetings except
reimbursement of out-of-pocket expenses. An outside director is reimbursed for out-of-pocket expenditures incurred in attending or otherwise participating in meetings. Upon agreeing to a service director each director is issued options to acquire
15,000 shares of our common stock at an exercise price of 25 cents. We have no other arrangements regarding compensation for services as a director.



During fiscal year ended 2004 our Board of Directors held one meeting at which all directors were present. We do not have a separate compensation or
nominating committee.



AUDIT COMMITTEE



The Audit Committee consists of the entire Board of Directors. The Audit
Committee selects the independent auditors; reviews the results and scope of the audit and other services provided by the Companys independent auditors, and reviews and evaluates the Companys internal control functions. The board of
directors has determined that E.J. Mersis is the audit committee financial expert, as such term is defined under federal securities law, and is not independent. Mr. Mersis is an expert by virtue of: (i) education and experience as a
principal financial officer, principal accounting officer, controller, public accountant or auditor or experience in one or more positions that involve the performance of similar functions; (ii) experience actively supervising a principal financial
officer, principal accounting officer, controller, public accountant, auditor or person performing similar functions; (iii) experience overseeing or assessing the performance of companies or public accountants with respect to the preparation,
auditing or evaluation of financial statements; and (iv) other relevant experience.



ITEM 10. EXECUTIVE COMPENSATION



EXECUTIVE
COMPENSATION



The following table shows the compensation
paid or accrued by the Company for the fiscal years ended June 30, 2004 and June 30, 2003 to or for the account of the Rose Smith, President and Chief Executive Officer and John E. Nohren, Jr., Chairman of the Board. No other executive officer or
director of the Company received benefits or an annual salary and bonus in excess of $100,000 or more during the stated period. Accordingly, the summary compensation table does not include compensation of other executive officers.



19



---

##### Table of Contents

SUMMARY COMPENSATION TABLE



|                          |  |                                            |        |              |   |                                 |  |                                |        |                     |         |                  |           |                                                           |   |  |   |       
|------------------------- |  | ------------------------------------------ | ------ | ------------ | - | ------------------------------- |  | ------------------------------ | ------ | ------------------- | ------- | ---------------- | --------- | --------------------------------------------------------- | - |  | - | ------
|ANNUAL COMPENSATION       |  | LONG-TERM COMPENSATION AWARDS             
|Name & Principal Position |  | Salary Received In Cash Or Deferred ($)(1) |        | Bonus ($)(2) |   | Other AnnualCompensation ($)(3) |  | RestrictedStockAward(s) (#)(4) |        | OPTIONS/SARS (#)(5) |         | LTIP Payouts ($) |           | All OtherCompensation Received in Cash or Deferred ($)(1)
|Fiscal 2003               |  |                                            |        |              |   |                                 |  |                                |        |                     |         |                  |           |                                                           |   |  |   |       
|John E. Nohren, Jr.       |  |                                            |       |              | $ | 30,000                          |  | $                              | 39,600 |                     | 763,000 |                  | 1,270,000 |                                                           |  |  | $ | 63,700
|Chairman, CFO, BOD        |  |                                            |        |              |   |                                 |  |                                |        |                     |         |                  |           |                                                           |   |  |   |       
|Rose Smith                |  | $                                          | 67,400 |              |   |                                |  | $                              | 1,100  |                     | 743,000 |                  | 1,250,000 |                                                           |  |  |   |       
|President and CEO         |  |                                            |        |              |   |                                 |  |                                |        |                     |         |                  |           |                                                           |   |  |   |       
|                          |  |                                            |        |              |   |                                 | 
|Fiscal 2004               |  |                                            |        |              |   |                                 |  |                                |        |                     |         |                  |           |                                                           |   |  |   |       
|John E. Nohren, Jr.       |  |                                            |       |              |   |                                |  | $                              | 82,500 |                     |        |                  |          |                                                           |  |  |   |       
|Chairman, BOD             |  |                                            |        |              |   |                                 |  |                                |       |                     |         |                  |           |                                                           |   |  |   |       
|Rose Smith                |  | $                                          | 82,500 |              |   |                                 |  |                                |        |                     |        |                  |          |                                                           |  |  |   |       
|President and CEO         |  |                                            |        |              |   |                                 |  |                                |        |                     |         |                  |           |                                                           |   |  |   |       
|Emanuel Mersis, CFO       |  |                                            |        |              |   |                                 |  |                                |        |                     |         |                  |           |                                                           |   |  |   |       

---

|(1) | Represents actual cash compensation paid as salary for Ms. Smith or payments for Mr. Nohren, as well as deferred compensation payable to them which was expensed during the
respective fiscal year.
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(2) | Mr. Nohren was awarded a $30,000 bonus for services by the Board of Directors during the fiscal year ended June 30, 2003.
|--- | -------------------------------------------------------------------------------------------------------------------------

|(3) | Represents premium payments for life insurance and automobile lease payments for Mr. Nohren. Represents life insurance premiums for Mrs. Smith.
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------

|(4) | Represents number of shares issued to the record executive officer in lieu of cash compensation. See Employment and Other Agreements.
|--- | ---------------------------------------------------------------------------------------------------------------------------------------

|(5) | Represents options exercisable at $.12 issued in granted to the officers by the Board of directors for continued service and loyalty to the Company, and other considerations. See
Employment and Other Agreements.
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



EMPLOYMENT AND
OTHER AGREEMENTS



We were party to an employment
agreement with Rose C. Smith effective June 30, 1997, which provided for her employment as President and Chief Executive Officer for a five year term ending June 29, 2002. Under the agreement Ms. Smith received a base salary of $150,000 per year.
Ms. Smith also was entitled to receive a bonus of two percent of net sales of the Company adjusted by the annual gross margin achieved by the Company. The agreement contained a restrictive covenant not to compete for the term of the agreement and
for five years following termination of service. The agreement provided for severance payments equal to 200% of the annual base compensation due under the Agreement in the event there is a change of control of the Company, as defined
therein, and she is subsequently terminated without cause. For the fiscal year ending June 30, 2002 and 2001, Ms. Smith voluntarily reduced her base salary to $110,000 per year. The base salary terms of this agreement were not renewed.



Due to the financial constraints and limited cash resources available to
the Company, we had an accrued obligation due Ms. Smith of $50,000 for unpaid salary for fiscal year ended 2002. Ms. Smith forgave this $50,000 debt during the fiscal year ended June 30, 2002. On October 9, 2002, the Board of Directors granted Ms.
Smith options to acquire 1,250,000 of our common stock exercisable at $0.12 per share with a ten (10) year term. These options were granted to her for her continuing service and loyalty to the Company as well as her agreeing to a reduction in her
annual salary and some debt forgiveness in prior years. The exercise price of $0.12 per share was based upon the value of our common shares as quoted on the OTC:BB as of June 30, 2002. The number of options equaled three times the number of shares
that would



20



---

##### Table of Contents

have otherwise been issued to Ms. Smith if she had elected to receive shares as opposed to options to satisfy the unpaid
compensation at a $0.12 per share valuation. We believe that this valuation technique is fair and consistent with independent valuation models employed by other companies.



A new employment agreement with Ms. Smith was created and extended until June 30, 2003 at a $110,000 annual base salary. The
Company and Ms. Smith agreed that one-half of her base salary could be paid in shares of the Companys common stock. The Company has elected to compensate part of Ms. Smith 2003 compensation, approximately $51,100, in shares of the
Companys common stock. The number of shares issued to Ms. Smith is based upon the closing price of the Companys common stock as of the end of each month. Accordingly, the Company was obligated to issue Ms. Smith 742,763 of its common
stock for compensation expense relating to fiscal year ended June 30, 2003.



Mrs. Smith agreed to a salary of $82,500 for the fiscal year ended June 30, 2004. At the end of the fiscal year ended June 30, 2004, total deferred compensation still payable to her totaled $223,700 and has been
expensed in the current reporting and prior fiscal years.



The
Company entered into an agreement with John E. Nohren, Jr. effective June 30, 1997, expiring on June 30, 2002. This agreement obligated the Company to pay Mr. Nohren a minimum of $100,000 per year, with a cap of $300,000 per year, during the term of
his employment. The payments were calculated based on five percent of net sales of products that incorporate certain patents assigned to the Company by Mr. Nohren.



The agreement with Mr. Nohren was amended during the fiscal year ended June 30, 2002 to increase payments to Mr. Nohren to
$110,000 per year and eliminating the provision for increased income up to $300,000 based upon five percent of sales of products covered under patents he has assigned to the Company. The agreement with Mr. Nohren was to expire on June 30, 2002 was
extended until a new agreement can be finalized by the parties. At the end of fiscal year 2002 Mr. Nohren was unpaid $50,800 of amounts due under this agreement. Mr. Nohren forgave this debt during the fiscal year ended June 30, 2002. On October 9,
2002, the Board of Directors granted Mr. Nohren options to acquire 1,270,000 of our common stock exercisable at $0.12 per share with a ten (10) year term. These options were granted to him for his continuing service and loyalty to the Company as
well as his agreeing to defer some of the payments that were due him and debt forgiveness in prior years. We employed the same valuation techniques for Mr. Nohrens options as we did for Ms. Smiths options as described above.



The agreement was further extended through fiscal year 2003, under which
he would receive an annual payment of $110,000, with the proviso that if the company was not financially able to pay, fifty percent would be paid in stock. Due to financial constraints and limited cash resources we elected to remunerate part of Mr.
Nohrens annual payments with shares of our common stock valued as of the closing price of our shares on the OTC: BB on the last day of each month. Based upon this valuation methodology, we were obligated to issue Mr. Nohren 762,544 of our
common stock for $55,600 of unpaid amounts. Mr. Nohren agreed to be paid $82,500 for the fiscal year ended June 30, 2004.



In our past SEC filings we disclosed the above arrangements with Mr. Nohren as relating to a Royalty Agreement. Mr. Mersis, our Audit Committee Chairman,
believes the characterization of such obligations as royalty payments is incorrect because the Company owns the patents and related rights, not Mr. Nohren. Accordingly, we have deleted all references to royalties due Mr. Nohren in this Form 10-KSB
and generally refer to such amounts as obligations and accrued payments.



21



---

##### Table of Contents

In addition, during the fiscal year ended June 30, 2003, the Board of Directors awarded Mr. Nohren a
$30,000 bonus in recognition of his innovative services to the Company over the years. This bonus did not require the distribution of cash to Mr. Nohren during the current reporting fiscal year, but rather involved the expensing of amounts recorded
as an account receivable due from him on the Companys books. This receivable was for a cash disbursement made to him in a prior year and that was deemed personal in nature in lieu of expense reports. At the end of the fiscal year ended June
30, 2004, total deferred payments still payable to Mr. Nohren totaled $93,900 and have been expensed in the current reporting and prior fiscal years.



AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR END OPTION VALUES



The information provided in the table below provides information with respect to each exercise of stock options during
fiscal 2004 and fiscal 2003 by each of the executive officers named in the summary compensation table and the fiscal year end value of unexercised options.



22



---

##### Table of Contents

|                    |  |                               |  |                           |  |                                                                                                          |     |  |                                                                                                                  
|------------------- |  | ----------------------------- |  | ------------------------- |  | -------------------------------------------------------------------------------------------------------- | --- |  | -----------------------------------------------------------------------------------------------------------------
|(a) Name            |  | (b) Shares Acquired/Exercised |  | (c) Value Realized ($)(1) |  | (d) Number of Unexercised OptionsIssued During FY-EndExercisable on or after July 1,2003 or July 1, 2004 |     |  | (e) Value of Unexercised In-theMoney Options at FY-End($) Exercisable on orafter July 1, 2003 or July 1, 2004 (1)
|Fiscal 2003         |  |                               |  |                           |  |                                                                                                          |     |  |                                                                                                                  
|John E. Nohren, Jr. |  |                              |  |                          |  | 1,270,000                                                                                                | (2) |  | 0                                                                                                                
|Rose Smith          |  |                              |  |                          |  | 1,250,000                                                                                                | (2) |  | 0                                                                                                                
|                    |  |                               |  |                          
|Fiscal 2004         |  |                              |  |                          |  |                                                                                                          |     |  |                                                                                                                  
|John E. Nohren, Jr. |  |                              |  |                          |  |                                                                                                         |     |  | 0                                                                                                                
|Rose Smith          |  |                              |  |                          |  |                                                                                                         |     |  | 0                                                                                                                

---

|(1) | The aggregate dollar values in column (c) and (e) are calculated by determining the difference between the fair market value of the Common Stock underlying the options and the
exercise price of the options at exercise or fiscal year end, respectively. In calculating the dollar value realized upon exercise, the value of any payment of the exercise price is not included.
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(2) | These options were granted for continued services and loyalty to the Company, and other considerations, and were approved by the Board of Directors and issued on October 9, 2002.
These options are exercisable at $0.12 through October 9, 2012. See Employment Agreements and Other Arrangements for more detailed description.
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



STOCK OPTIONS



The Company had in effect a stock option plan, which authorizes the grant of incentive stock options under Section 422 of the Internal Revenue Code (the
1996 Plan). The Plan was adopted in 1996. A total of 750,000 shares had been reserved under the Plan. As of June 30, 2003, options to purchase a total of approximately 584,600 shares at $.50 a share were outstanding under the 1996 Plan.
The 1996 Plan provided that (a) the exercise price of options granted under the Plan shall not be less than the fair market value of the shares on the date on which the option is granted unless an employee, immediately before the grant, owns more
than 10% of the total combined voting power of all classes of stock of the Company or any subsidiaries, whereupon the exercise price shall be at least 110% of the fair market value of the shares on the date on which the option is granted; (b) the
term of the option may not exceed ten years and may not exceed five years if the employee owns more than 10% of the total combined voting power of all classes of stock of the Company or any subsidiaries immediately before the grant; (c) the shares
of stock may not be disposed of for a period of two years from the date of grant of the option and for a period of one year after the transfer of such shares to the employee; and (d) at all time from the date of grant of the option and ending on the
date three months before the date of the exercise, the employee shall be employed by Company, or a subsidiary of the Company, unless employment is terminated because of disability, in which cased such disabled employee shall be employed from date of
grant to a year preceding the date of exercise, or unless such employment is terminated due to death. During 2001, all of the 1996 stock options were forfeited.



In April 1999, the Board of Directors adopted a new stock option plan (the 1999 Plan). Under the 1999 Plan, 1,000,000 shares had been
reserved for issuance. The Plan provides that the exercise price of options cannot be less than the greater of $.50 or the fair market value of the shares from the date on which the option is granted. The 1999 Plan is similar to all of the other
terms and conditions as described above for the 1996 Plan.



As
of June 30, 2004, options to purchase a total of approximately 100,000 shares with an exercise price of $.50 per share were outstanding under the 1999 Plan. These options are exercisable at any time and expire in April 2009.



23



---

##### Table of Contents

During the year ended June 30, 2002, the Companys 1999 Stock Option Plan was amended to allow the
remaining options to be granted at an option price not less than the greater of $.25 per share or 100 percent of the fair market value of the underlying stock on the date of the grant. During the year ended June 30, 2002, an additional 755,000 stock
options at $.25 per share were granted under the 1999 Stock Option Plan. At June 30, 2004, 660,000 of these options are outstanding and are exercisable anytime through August 31, 2006.



On March 26, 2002, the Company entered into an agreement with an individual to provide marketing activities to the Company.
In exchange for these services, this individual was granted 1.2 million options as compensation. These options are immediately exercisable; expire in five years, with the following terms:



400,000 warrants may be converted into 400,000 shares of Innova stock at
$.50



400,000 warrants may be converted into 400,000 shares of
Innova stock at $.75



400,000 warrants may be converted into
400,000 shares of Innova stock at $1.00



Originally, we treated
this individual as an employee at will under Florida law. This individual is related to the funding source of a $400,000 interest free loan we received as part of an overall transaction between this individual and his affiliated entity. Because this
individual was originally treated as an employee, no compensation expense or imputed expense was recorded during fiscal year ended June 30, 2002 relating to this transaction. As a result of comments from the staff of the Securities and Exchange
Commission, Innova has reconsidered the accounting treatment for this transaction. Although we believe there is a reasonable basis to treat this individual as an employee, Innova recognizes the relationship between this individual and the entity
that advanced us $400,000 on an interest free loan. Accordingly, we will treat the fair market value of these options as prepaid interest at the time of the transaction amortizing this amount over the term of the loan. This results in a $9,000
adjustment to interest expense for fiscal year ended June 30, 2002, which is reflected in this years financial statements. The interest expense adjustment relating to this transaction is $36,000 for fiscal year ended June 30, 2003.



During the year ended June 30, 2004, the Company entered into an agreement
to issue a non-exclusive right to a patent in satisfaction of $200,000 of the note payable and cancellation of 800,000 common stock options. As a result of the cancellation of options, the unused value of these options was credited to additional
paid in capital. For the year ended June 30, 2004 and 2003, the Company amortized $12,200 and $45,000, respectively, of the discount to interest expense.



As of June 30, 2004, options outstanding and exercisable under this agreement are as follows:



200,000 warrants may be converted into 200,000 shares of Innova stock at
$.50



200,000 warrants may be converted into 200,000 shares of
Innova stock at $.75



The following table sets forth
information with respect to our common stock that may be issued upon the exercise of outstanding options, warrants, and rights to purchase shares of our common stock as of June 30, 2004.



24



---

##### Table of Contents

|                             |  |                                                                                                  |  |                                                                                  |     |                                                                                                                                                 |          
|---------------------------- |  | ------------------------------------------------------------------------------------------------ |  | -------------------------------------------------------------------------------- | --- | ----------------------------------------------------------------------------------------------------------------------------------------------- | ---------
|Plan Category                |  | (a) Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants, and Rights |  | (b) Weighted Average Exercise Price of Outstanding Options, Warrants, and Rights |     | (c) Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in
Column (a))
|Equity Compensation Plans    |  | -0-                                                                                              |  |                                                                                  | N/A |                                                                                                                                                 | N/A      
|Approved by Stockholders     |  |                                                                                                  |  |                                                                                  |     |                                                                                                                                                 |          
|Equity Compensation Plans    |  | 2,580,000                                                                                        |  | $                                                                                | .19 |                                                                                                                                                 | 1,100,000
|Not Approved by Stockholders |  |                                                                                                  |  |                                                                                  |     |                                                                                                                                                 |          
|Total                        |  |                                                                                                  |  |                                                                                  |     |                                                                                                                                                 |          



During the year ended
June 30, 2003, the Company issued 2,520,000 options exercisable over 10 years, to two officers of the Company at an exercise price of $.12 per share. These options were granted for their continuing services and loyalty to the Company as well as
their agreement to reduce or defer their compensation and debt forgiveness in prior years.



ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT



The following table sets forth certain information with respect to the beneficial ownership of shares of Company Common Stock owned as of June 30, 2004
beneficially by (i) each person who beneficially owns more than 5% of the outstanding Company Common Stock, (ii) each director of the Company, (iii) the Chairman and Treasurer, and the President and Chief Executive Officer of the Company (the only
executive officers of the Company whose cash and non-cash compensation for services rendered to the Company for the year ended June 30, 2004, exceeded $100,000) and (iv) directors and executive officers of the Company as a group:



|                                                     |  |                                               |  |                     
|---------------------------------------------------- |  | --------------------------------------------- |  | --------------------
|Name of Beneficial Owner (3)                         |  | Amount and Nature of Beneficial Ownership (1) |  | Percent of Class (2)
|John E. Nohren, Jr. and Francis Weaver Nohren (4)(5) |  | 4,548,093                                     |  | 37                  
|Rose C. Smith (6)                                    |  | 2,622,613                                     |  | 21                  
|Peter Christensen (8)                                |  | 624,500                                       |  | 5                   
|Joe Cayre (7)                                        |  | 1,350,000                                     |  | 11                  
|Emanuel Mersis(8)                                    |  | 51,404                                        |  | 0.4                 
|All directors and executive officers                 |  | 9,196,610                                     |  | 74                  
|As a group (6 persons)                               |  |                                               |  |                     

---

|(1) | Represents sole voting and investment power unless otherwise indicated.
|--- | -----------------------------------------------------------------------



25



---

##### Table of Contents

|(2) | Based on approximately 12,423,601 shares of Company Common Stock outstanding as of June 30, 2004 plus, as to each person listed, that portion of the unissued shares of Company
Common Stock subject to outstanding options which may be exercised by such person, and as to all directors and executive officers as a group, unissued shares of Company Common Stock as to which the members of such group have the right to acquire
beneficial ownership upon the exercise of stock options within the next 60 days, or 17,018,765 shares.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(3) | The address of each individual is in care of the Company.
|--- | ---------------------------------------------------------

|(4) | May be deemed to be a founder of the Company for the purpose of the Securities Act.
|--- | -------------------------------------------------------------------------------------

|(5) | Represents aggregate shares held between Mr. Nohren individually, his wife individually and shares held in joint tenancy. Includes options to acquire 215,000 shares of Common Stock
exercisable at $.25 held by Mr. Nohren. Also includes options to acquire 1,270,000 shares of Common Stock exercisable at $.12 held by Mr. Nohren.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(6) | 54,350 of the shares of common stock as set forth above are owned by Elliot Smith, husband of Rose C. Smith, President and Chief Executive Officer of the Company. Includes 215,000
shares underlying options issued to Ms. Smith with an exercise price of $.25. Also includes options to acquire 1,250,000 shares of Common Stock exercisable at $.12 held by Ms. Smith.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(7) | Represents shares held directly and indirectly by Joe Cayre and his family pursuant to an agreement reached between the Company and the Good Times family of companies.
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(8) | Includes options to acquire 15,000 shares of Common Stock at an exercise price of $.25 conditioned upon continued service as an outside director.
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------



ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS



See Executive Compensation  Employment and Other Agreements for a description of transactions between Innova and Mr. Nohren and Mrs. Smith.



26



---

##### Table of Contents

ITEM 13. EXHIBITS, LISTS AND REPORTS ON FORM 8-K



(a) Exhibits.



|       |  |                                                                                                                                                                                                                                                                                                                           |  |         
|------ |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  | --------
|Number |  | Title of Document                                                                                                                                                                                                                                                                                                         |  | Location
|3(a)   |  | Articles of Incorporation, as amended (1)                                                                                                                                                                                                                                                                                 |  |         
|3(b)   |  | Bylaws (1)                                                                                                                                                                                                                                                                                                                |  |         
|4(a)   |  | Specimen Certificate (1)                                                                                                                                                                                                                                                                                                  |  |         
|4(b)   |  | 1996 Incentive Stock Option Plan (1)                                                                                                                                                                                                                                                                                      |  |         
|4(c)   |  | 1999 Incentive Stock Option Plan (1)                                                                                                                                                                                                                                                                                      |  |         
|10(a)  |  | [Reserved]                                                                                                                                                                                                                                                                                                                |  |         
|10(b)  |  | Agreement with Rubbermaid Incorporated dated July 21, 1998 (1)                                                                                                                                                                                                                                                            |  |         
|10(c)  |  | [Reserved]                                                                                                                                                                                                                                                                                                                |  |         
|10(d)  |  | Stock Purchase/Warrant Exchange Agreement with GoodTimes Entertainment, Inc. dated October 11, 1997 (1)                                                                                                                                                                                                                   |  |         
|10(e)  |  | Employment Agreement with Rose C. Smith dated June 30, 1997 (1)                                                                                                                                                                                                                                                           |  |         
|10(f)  |  | Royalty Agreement with John E. Nohren, Jr. dated June 30, 1997 (1)                                                                                                                                                                                                                                                        |  |         
|10(g)  |  | License Agreement with A. C. International dated May 21, 1998 (1)                                                                                                                                                                                                                                                         |  |         
|10(h)  |  | Supply and Distribution Agreement with Bowline Family Products, Inc. Dated September 26, 1997 (1)                                                                                                                                                                                                                         |  |         
|10(i)  |  | [Reserved]                                                                                                                                                                                                                                                                                                                |  |         
|10(j)  |  | Purchase and Supply Agreement with Rose Group dated January 22, 1997 (terminated) (1)                                                                                                                                                                                                                                     |  |         
|10(k)  |  | Real Estate Lease with Carr Rubin Associates dated January 21, 1998(1)                                                                                                                                                                                                                                                    |  |         
|10(l)  |  | Stock Option Agreement with Rose Smith for unpaid 2002 salary (1)                                                                                                                                                                                                                                                         |  |         
|10(m)  |  | Stock Option Agreement with Jack Nohren for 2002 unpaid royalties (1)                                                                                                                                                                                                                                                     |  |         
|10(n)  |  | Letter Agreement between the Company and Rose Smith regarding fiscal 2003 compensation arrangement (1)                                                                                                                                                                                                                    |  |         
|10(o)  |  | Letter Agreement between the Company and Jack Nohren regarding fiscal 2003 royalty arrangement (1)                                                                                                                                                                                                                        |  |         
|10(p)  |  | Agreement by and between Sawyer Products, Curt Avery and the Company regarding $400,000 loan and issuance of 1,2000 Warrants (1)                                                                                                                                                                                          |  |         
|10(q)  |  | Distribution Agreement with CamelBak Products (1)                                                                                                                                                                                                                                                                         |  |         
|31.1   |  | Certification of the Chief Executive Officer, dated October 13, 2004 (This certification required as Exhibit 31 under Item 601(a) of Regulation S-K is filed as Exhibit 31.1 pursuant to SEC
interim filing guidance.) (2)                                                                                                |  |         
|31.2   |  | Certification of the Interim Chief Financial Officer, dated October 13, 2004. (This certification required as Exhibit 31 under Item 601(a) of Regulation S-K is filed as Exhibit 31.2 pursuant
to SEC interim filing guidance.) (2)                                                                                       |  |         
|32     |  | Written Statements of the Chief Executive Officer and Chief Financial Officer, dated October 13, 2004 (This certification required as Exhibit 32 under Item 601(a) of Regulation S-K is
furnished in accordance with Item 601(b) (32) (iii) of Regulation S-K as Exhibit 32 pursuant to SEC interim filing guidance.) (2) |  |         

---

|(1) | All of the items below are incorporated by reference to the Companys Registration Statement on Form 10SB (SEC File No. 000-14988).
|--- | -----------------------------------------------------------------------------------------------------------------------------------

|(2) | Filed herewith
|--- | --------------



(b) Reports on Form 8-K



None



27



---

##### Table of Contents

ITEM 14 PRINCIPAL ACCOUNTANT FEES AND SERVICES



COMPENSATION OF AUDITORS



Pender, Newkirk and
Company billed the Company an aggregate of $34,981 and $34,257 in fees and expenses for professional services rendered in connection with the audit and reviews of the Companys financial statements during the fiscal year ended June 30, 2004 and
2003, respectively to be included in reports filed with the Securities and Exchange Commission.



Financial Information Systems Design and Implementation Fees. Pender, Newkirk and Company did not provide the Company any professional services for
financial information systems design or implementation for the fiscal years ended June 30, 2004 and 2003.



All Other Fees. Pender, Newkirk and Company billed the Company an aggregate of $3,108 and $2,000 in fees and expenses during the years ended June 30, 2004
and 2003, respectively, primarily for the following professional services:



|                         |  |      |       |      |   |      
|------------------------ |  | ---- | ----- | ---- | - | -----
|                         |  | 2003 |       | 2002
|Audited related services |  | $    | -0-   |      | $ | -0-  
|Taxes                    |  | $    | 3,108 |      | $ | 2,000
|Other                    |  | $    | -0-   |      | $ | -0-  



28



---

##### Table of Contents

Signatures



Pursuant to the
requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



|                        |  |                        |  |                                           
|----------------------- |  | ---------------------- |  | ------------------------------------------
|                        |  | INNOVA PURE WATER, INC
|                        |  |                       
|Dated: October 28, 2004 |  | By:                    |  | /s/ Rose C. Smith                         
|                        |  |                        |  | Rose C. Smith                             
|                        |  |                        |  | President, Chief Executive Officer,       
|                        |  |                        |  | Director                                  
|                        |  |                       
|Dated: October 28, 2004 |  | By:                    |  | /s/ Emanuel Mersis.                       
|                        |  |                        |  | Emanuel Mersis                            
|                        |  |                        |  | Interim Chief Financial Officer, Principal
|                        |  |                        |  | Accounting Officer                        



Pursuant to the
requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.



|                        |  |     |  |                                           
|----------------------- |  | --- |  | ------------------------------------------
|Dated: October 28, 2004 |  | By: |  | /s/ John E. Nohren, Jr.                   
|                        |  |     |  | John E. Nohren, Jr.                       
|                        |  |     |  | Chairman of the Board of Directors,       
|                        |  |    
|Dated: October 28, 2004 |  | By: |  | /s/ Rose C. Smith                         
|                        |  |     |  | Rose C. Smith                             
|                        |  |     |  | President, Chief Executive Officer,       
|                        |  |     |  | Director                                  
|                        |  |    
|Dated: October 28, 2004 |  | By: |  | /s/ Emanuel Mersis                        
|                        |  |     |  | Emanuel Mersis, Director                  
|                        |  |     |  | Interim Chief Financial Officer, Principal
|                        |  |     |  | Accounting Officer                        
|                        |  |    
|Dated: October 28, 2004 |  | By: |  | /s/ Peter E. Christensen                  
|                        |  |     |  | Peter E. Christensen, Director            



29



---

##### Table of Contents

Financial Statements



Years Ended June 30,
2004 and 2003



Contents



|                                                                                   |  |    
|---------------------------------------------------------------------------------- |  | ---
|Report of Independent Registered Accounting Firm on Condensed Financial Statements |  | F-2
|                                                                                   | 
|Financial Statements:                                                              |  |    
|                                                                                   | 
|Balance Sheet                                                                      |  | F-3
|Statements of Operations                                                           |  | F-4
|Statements of Changes in Stockholders Equity (Deficit)                            |  | F-5
|Statements of Cash Flows                                                           |  | F-6
|Notes to Financial Statements                                                      |  | F-7



F-1



---

##### Table of Contents

Report of Independent Registered Public Accounting Firm



Board of Directors

Innova Pure Water, Inc.

Clearwater, Florida



We have audited the accompanying balance sheet of
Innova Pure Water, Inc. as of June 30, 2004 and the related statements of operations, changes in stockholders equity (deficit), and cash flows for the years ended June 30, 2004 and 2003. These financial statements are the responsibility of the
management of Innova Pure Water, Inc. Our responsibility is to express an opinion on these financial statements based on our audits.



We conducted our audits in accordance with standards of the Public Company Accounting Oversight Board (United States). These standards require that we plan and perform
the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.



In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Innova Pure Water, Inc. as of June 30, 2004 and the results of its operations and its cash flows for the years ended June 30, 2004 and 2003 in conformity with accounting principles generally
accepted in the United States of America.



The accompanying financial
statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has negative working capital of $670,700, a net loss of approximately $282,800 as of and for
the year ended June 30, 2004 and has incurred substantial net losses in the previous years resulting in an accumulated deficit of approximately $9,127,300. These conditions raise substantial doubt about the Companys ability to continue as a
going concern. Managements plans regarding those matters also are described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.



Pender Newkirk & Company

Certified Public Accountants

Tampa, Florida

September 24, 2004



F-2



---

##### Table of Contents

Innova Pure Water, Inc.



Balance
Sheet



June 30, 2004



|                                                                                                                         |  |   |            |  
|------------------------------------------------------------------------------------------------------------------------ |  | - | ---------- | -
|Assets                                                                                                                   |  |   |            |  
|Current assets:                                                                                                          |  |   |            |  
|Cash, restricted                                                                                                         |  | $ | 67,000     |  
|Accounts receivable, trade                                                                                               |  |   | 39,200     |  
|Other receivables, net of allowance for doubtful accounts of $2,000                                                      |  |   | 7,200      |  
|Inventories                                                                                                              |  |   | 19,500     |  
|Prepaid expenses                                                                                                         |  |   | 1,800      |  
|                                                                                                                         |  |   |            |  
|Total current assets                                                                                                     |  |   | 134,700    |  
|                                                                                                                         | 
|Property and equipment, net                                                                                              |  |   | 15,200     |  
|                                                                                                                         | 
|Other assets:                                                                                                            |  |   |            |  
|Patents, net of accumulated amortization of $527,800                                                                     |  |   | 205,200    |  
|Other receivables, related party, net of allowance for doubtful accounts of $18,000                                      |  |   | 100        |  
|Other                                                                                                                    |  |   | 5,700      |  
|                                                                                                                         |  |   |            |  
|Total other assets                                                                                                       |  |   | 211,000    |  
|                                                                                                                         | 
|                                                                                                                         |  | $ | 360,900    |  
|                                                                                                                         |  |   |            |  
|Liabilities and Stockholders Equity (Deficit)                                                                           |  |   |            |  
|Current liabilities:                                                                                                     |  |   |            |  
|Bank overdraft                                                                                                           |  | $ | 13,600     |  
|Accounts payable, trade                                                                                                  |  |   | 211,100    |  
|Accrued expenses                                                                                                         |  |   | 49,800     |  
|Deferred compensation                                                                                                    |  |   | 317,600    |  
|Deferred revenue                                                                                                         |  |   | 213,300    |  
|                                                                                                                         |  |   |            |  
|Total current liabilities                                                                                                |  |   | 805,400    |  
|                                                                                                                         |  |   |            |  
|Long-term liabilities:                                                                                                   |  |   |            |  
|Note Payable net of unamortized discount of $35,600                                                                      |  |   | 164,400    |  
|                                                                                                                         |  |   |            |  
|Stockholders equity (deficit):                                                                                          |  |   |            |  
|Preferred stock; $.001 par value; 2,000,000 shares authorized; 0 shares issued and outstanding                           |  |   |            |  
|Common stock; $.0001 par value; 50,000,000 shares authorized; 12,449,684 shares issued and 12,423,601 shares outstanding |  |   | 1,200      |  
|Capital in excess of par value                                                                                           |  |   | 8,530,100  |  
|Accumulated deficit                                                                                                      |  |   | (9,127,300 | )
|                                                                                                                         |  |   |            |  
|                                                                                                                         |  |   | (596,000   | )
|Treasury stock, at cost; 26,083 shares                                                                                   |  |   | (12,900    | )
|                                                                                                                         |  |   |            |  
|Total stockholders deficit                                                                                              |  |   | (608,900   | )
|                                                                                                                         |  |   |            |  
|                                                                                                                         |  | $ | 360,900    |  
|                                                                                                                         |  |   |            |  



The accompanying notes are an
integral part of the financial statements.



F-3



---

##### Table of Contents

Innova Pure Water, Inc.



Statements of
Operations



|                                                     |  |                     |            |   |      |   |            |  
|---------------------------------------------------- |  | ------------------- | ---------- | - | ---- | - | ---------- | -
|                                                     |  | Year Ended June 30, |           
|                                                     |  | 2004                |            |   | 2003 |  
|Sales                                                |  | $                   | 671,300    |   |      |   | 608,000    |  
|                                                     |  |                    
|Cost of sales                                        |  |                     | 396,500    |   |      |   | 343,400    |  
|                                                     |  |                     |            |   |      |   |            |  
|Gross profit                                         |  |                     | 274,800    |   |      |   | 264,600    |  
|                                                     |  |                     |            |   |      |   |            |  
|Operating expenses:                                  |  |                     |            |   |      |   |            |  
|Selling expenses                                     |  |                     | 200        |   |      |   | 1,700      |  
|General and administrative expenses                  |  |                     | 650,100    |   |      |   | 764,100    |  
|Research and product development                     |  |                     | 10,100     |   |      |   | 92,300     |  
|                                                     |  |                     |            |   |      |   |            |  
|                                                     |  |                     | 660,400    |   |      |   | 858,100    |  
|                                                     |  |                     |            |   |      |   |            |  
|Net loss from operations                             |  |                     | (385,600   | ) |      |   | (593,500   | )
|                                                     |  |                     |            |   |      |   |            |  
|Other (income) expenses:                             |  |                     |            |   |      |   |            |  
|Interest                                             |  |                     | 31,800     |   |      |   | 56,500     |  
|Royalties and other income                           |  |                     | (134,600   | ) |      |   | (70,100    | )
|                                                     |  |                     |            |   |      |   |            |  
|                                                     |  |                     | (102,800   | ) |      |   | (13,600    | )
|                                                     |  |                     |            |   |      |   |            |  
|Net loss                                             |  | $                   | (282,800   | ) |      | $ | (579,900   | )
|                                                     |  |                     |            |   |      |   |            |  
|Loss earnings per common share                       |  | $                   | (.02       | ) |      | $ | (.05       | )
|                                                     |  |                     |            |   |      |   |            |  
|Weighted average number of common shares outstanding |  |                     | 12,182,781 |   |      |   | 11,129,290 |  
|                                                     |  |                     |            |   |      |   |            |  



The accompanying notes are an
integral part of the financial statements.



F-4



---

##### Table of Contents

Innova Pure Water, Inc.



Statements of
Changes in Stockholders Equity (Deficit)



Years Ended
June 30, 2004 and 2003



|                                                                   |  |              |  |                                |       |  |                     |           |   |                |   |            |   |  |   |         |  
|------------------------------------------------------------------ |  | ------------ |  | ------------------------------ | ----- |  | ------------------- | --------- | - | -------------- | - | ---------- | - |  | - | ------- | -
|                                                                   |  | Common Stock |  | Capital In Excess Of Par Value |       |  | Accumulated Deficit |           |   | Treasury Stock |  
|                                                                   |  | Shares       |  | Amount                         |       |  |                    
|Balance, June 30, 2002                                             |  | 10,498,543   |  | $                              | 1,000 |  | $                   | 8,462,200 |   |                | $ | (8,264,600 | ) |  | $ | (15,300 | )
|                                                                   |  |              |  |                                |      
|Issuance of common stock for services                              |  | 200,000      |  |                                |       |  |                     | 24,000    |   |                |   |            |   |  |   |         |  
|Issuance of treasury stock for services, 15,000 shares             |  |              |  |                                |       |  |                     |           |   |                |   |            |   |  |   | 1,900   |  
|                                                                   |  |              |  |                                |      
|Issuance of common stock for accrued compensation                  |  | 1,505,307    |  |                                | 200   |  |                     | 106,500   |   |                |   |            |   |  |   |         |  
|Net loss                                                           |  |              |  |                                |       |  |                     |           |   |                |   | (579,900   | ) |  |   |         |  
|                                                                   |  |              |  |                                |       |  |                     |           |   |                |   |            |   |  |   |         |  
|Balance, June 30, 2003                                             |  | 12,203,850   |  | $                              | 1,200 |  | $                   | 8,592,700 |   |                | $ | (8,844,500 | ) |  | $ | (13,400 | )
|                                                                   |  |              |  |                                |      
|Issuance of treasury stock for services, 4,002 shares              |  |              |  |                                |       |  |                     |           |   |                |   |            |   |  |   | 500     |  
|                                                                   |  |              |  |                                |      
|Value of options returned in connection with sale of patent rights |  |              |  |                                |       |  |                     | (87,200   | ) |                |   |            |   |  |   |         |  
|                                                                   |  |              |  |                                |      
|Issuance of common stock for services                              |  | 245,834      |  |                                |       |  |                     | 24,600    |   |                |   |            |   |  |   |         |  
|Net loss                                                           |  |              |  |                                |       |  |                     |           |   |                |   | (282,800   | ) |  |   |         |  
|                                                                   |  |              |  |                                |       |  |                     |           |   |                |   |            |   |  |   |         |  
|Balance, June 30, 2004                                             |  | 12,449,684   |  | $                              | 1,200 |  | $                   | 8,530,100 |   |                | $ | (9,127,300 | ) |  | $ | (12,900 | )
|                                                                   |  |              |  |                                |       |  |                     |           |   |                |   |            |   |  |   |         |  



The accompanying notes are an integral
part of the financial statements.



F-5



---

##### Table of Contents

Innova Pure Water, Inc.



Statements of
Cash Flows



|                                                                                    |  |                     |          |   |      |   |          |  
|----------------------------------------------------------------------------------- |  | ------------------- | -------- | - | ---- | - | -------- | -
|                                                                                    |  | Year Ended June 30, |         
|                                                                                    |  | 2004                |          |   | 2003 |  
|Operating activities                                                                |  |                     |          |   |      |   |          |  
|Net loss                                                                            |  | $                   | (282,800 | ) |      | $ | (579,900 | )
|                                                                                    |  |                     |          |   |      |   |          |  
|Adjustments to reconcile net loss to net cash provided by operating activities:     |  |                     | 119,500  |   |      |   | 143,900  |  
|Depreciation and amortization                                                       |  |                     |          |   |      |   |          |  
|Common stock issued for services                                                    |  |                     | 25,100   |   |      |   |          |  
|Change in provision for doubtful accounts                                           |  |                     |          |   |      |   | (9,900   | )
|Compensation for stock issued for services                                          |  |                     |          |   |      |   | 132,600  |  
|Amortization of note payable discount                                               |  |                     | 12,200   |   |      |   | 45,000   |  
|Increase of deferred compensation of related parties                                |  |                     | 157,700  |   |      |   | 47,700   |  
|(Increase) decrease in:                                                             |  |                     |          |   |      |   |          |  
|Accounts and other receivables                                                      |  |                     | (15,600  | ) |      |   | 164,500  |  
|Inventories                                                                         |  |                     | 89,400   |   |      |   | 81,100   |  
|Other assets and prepaid expenses                                                   |  |                     | 7,300    |   |      |   | 20,900   |  
|(Decrease) increase in:                                                             |  |                     |          |   |      |   |          |  
|Accounts payable and accrued expenses                                               |  |                     | (49,400  | ) |      |   | (76,500  | )
|Deferred revenue                                                                    |  |                     | (58,400  | ) |      |   | 64,400   |  
|                                                                                    |  |                     |          |   |      |   |          |  
|Total adjustments                                                                   |  |                     | 287,800  |   |      |   | 613,700  |  
|                                                                                    |  |                     |          |   |      |   |          |  
|Net cash provided by operating activities                                           |  |                     | 5,000    |   |      |   | 33,800   |  
|                                                                                    |  |                     |          |   |      |   |          |  
|Investing activities                                                                |  |                     |          |   |      |   |          |  
|Increase in restricted cash                                                         |  |                     | (67,000  | ) |      |   |          |  
|Acquisition of patents                                                              |  |                     |          |   |      |   | (26,200  | )
|Acquisition of equipment                                                            |  |                     | (400     | ) |      |   | (1,300   | )
|                                                                                    |  |                     |          |   |      |   |          |  
|Net cash used by investing activities                                               |  |                     | (67,400  | ) |      |   | (27,500  | )
|                                                                                    |  |                     |          |   |      |   |          |  
|Financing activities                                                                |  |                     |          |   |      |   |          |  
|Increase in bank overdraft                                                          |  |                     | 13,600   |   |      |   |          |  
|                                                                                    |  |                     |          |   |      |   |          |  
|Net cash provided by financing activities                                           |  |                     | 13,600   |   |      |   |          |  
|                                                                                    |  |                     |          |   |      |   |          |  
|Net increase in cash                                                                |  |                     | (48,800  | ) |      |   | 6,300    |  
|                                                                                    |  |                    
|Cash, beginning of year                                                             |  |                     | 48,800   |   |      |   | 42,500   |  
|                                                                                    |  |                     |          |   |      |   |          |  
|Cash, end of year                                                                   |  | $                   | 0        |   |      | $ | 48,800   |  
|                                                                                    |  |                     |          |   |      |   |          |  
|Supplemental disclosures of cash flow information and noncash financing activities: |  |                     |          |   |      |   |          |  
|Cash paid during the year for interest                                              |  | $                   | 0        |   |      | $ | 0        |  
|                                                                                    |  |                     |          |   |      |   |          |  



During the fiscal year ended June 30,
2004, the Company entered into an agreement to issue a non-exclusive right to a patent in satisfaction of $200,000 of the note payable and cancellation of 800,000 common stock options. As a result of the cancellation of options, the unused value of
these options was credited to additional paid in capital.



During the fiscal
years June 30, 2004 and 2003, the Company incurred $19,800 and $7,400 of payables, respectively, for the acquisition and defense of patents, and acquisition of trademarks.



During the fiscal year ended June 30, 2004, the Company issued $500 of treasury stock in exchange for web site development services.



During the fiscal year ended June 30, 2003, the Company incurred $6,900 of
payables for the acquisition on new tooling.



During the year ended June 30,
2003, The Company applied $30,000 in expensed compensation to a shareholders account receivable in a cashless transaction.



The accompanying notes are an integral part of the financial statements.



F-6



---

##### Table of Contents

Innova Pure Water, Inc.



Notes to
Financial Statements



Years Ended June 30, 2004 and 2003



1. Nature of Operations



Innova Pure Water, Inc. was incorporated in Florida in 1985 for the purpose of developing,
manufacturing, and marketing proprietary, state-of-the-art, effective, and economical in-the-house and portable water purification products. The corporate headquarters is located in Clearwater, Florida. Sales are to both wholesale and retail markets
throughout the United States, principally on credit and primarily through strategic alliances. Sales are also made to distributors in several foreign countries.



For the years ended June 30, 2004 and 2003, sales to major customers are as follows:



|                   |  |      |         |  |      |   |  |   |         |  |    |  
|------------------ |  | ---- | ------- |  | ---- | - |  | - | ------- |  | -- | -
|                   |  | 2004 |         |  | 2003 |  
|Nikken/Kenko World |  | $    | 368,600 |  | 55   | % |  | $ | 255,500 |  | 42 | %
|Sawyer Products    |  | $    | 267,300 |  | 40   | % |  | $ | 151,900 |  | 25 | %
|CamelBak           |  |      |         |  |      |   |  | $ | 119,500 |  | 20 | %



Accounts receivable from these
customers amounted to approximately $39,200 and $22,700 at June 30, 2004 and 2003, respectively.



For the years ended June 30, 2004 and 2003, sales to foreign customers amounted to approximately 1 percent of net sales to unaffiliated customers, respectively. These sales were made to customers in various locations
as follows:



|            |  |      |       |      |   |      
|----------- |  | ---- | ----- | ---- | - | -----
|            |  | 2004 |       | 2003
|New Zealand |  |      |       |      | $ | 5,000
|Canada      |  | $    | 2,400 |      |   | 2,000
|Japan       |  |      | 6,000 |      |   |      
|Other       |  |      | 500   |      |   |      
|            |  |      |       |      |   |      
|            |  | $    | 8,900 |      | $ | 7,000
|            |  |      |       |      |   |      



The Company currently holds numerous
patents assigned to them by a stockholder, in the field of water treatment and has additional domestic and foreign patents pending. The Company pursues an aggressive product development program with the goal to provide its strategic partners with
unique competitive advantages.



2. Going
Concern



The accompanying financial statements have been prepared in
conformity with accounting principles generally accepted in the United States of America, which contemplates continuation of the Company as a going concern. However, the Company has sustained substantial operating losses in recent years. Further,
for the year ended June 30, 2004, the Company had negative working capital of $670,700, a net loss of approximately $282,800 and has incurred substantial net losses in the previous years resulting in an accumulated deficit of approximately
$9,127,300. These factors raise substantial doubt about the ability of the Company to continue



F-7



---

##### Table of Contents

Innova Pure Water, Inc.



Notes to Financial Statements



Years Ended June 30, 2004 and 2003



2. Going Concern (continued)



as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.



Although the Company continues to maintain costs and institute efforts to conserve cash, such
efforts will not make them a viable business entity, and without significant additional revenues they may not be able to stay in business. Two chief executive officers have agreed to defer a substantial portion of their compensation and payments.



The Company continues to explore the possibility of outsourcing some
production and support tasks that are currently being done in-house in order to reduce such costs. However, until sufficient volume is obtained to support significant outsourcing, the Company is not in a position to outsource production in order to
save costs.



The Company has not been successful in attracting outside capital.
They continue to pursue capital raising opportunities; however, no assurance can be given that the Company would be able to raise any outside capital or that such funds will be available to them on favorable terms. If the Company raises additional
funds through the issuance of equity or debt securities, such securities may have rights, preferences or privileges senior to those of the rights of common stock and stockholders may experience substantial additional dilution.



Although the Company has not experienced any difficulty in securing the necessary raw
materials from vendors, the Company is on payment schedules with some vendors, and if they fail to maintain these payments or if these vendors require satisfaction of outstanding obligations to fulfill new orders, the Companys operations could
be adversely affected.



The Company continuously discusses opportunities with
new potential strategic alliance partners. Unfortunately, they have not procured any new significant strategic alliances in fiscal year 2004 and there is no assurance that they will enter into any new alliances in fiscal 2005. To date, arrangements
with CamelBak, Sawyer Products and Nikken have not generated significant revenues and it does not appear these alliances will result in significant revenues for fiscal 2005. The Company continues to have discussions with other businesses regarding
merging a private company into Innova that has a complimentary business or product lines, although they have not been able to finalize the terms of any proposed acquisitions. They will continue to explore this possibility in fiscal 2005.



3. Significant Accounting Policies



The significant accounting policies followed are:



The preparation of financial statements in conformity with accounting principles generally
accepted in the United States of America requires management to make estimates and



F-8



---

##### Table of Contents

Innova Pure Water, Inc.



Notes to Financial Statements



Years Ended June 30, 2004 and 2003



3. Significant Accounting Policies (continued)



assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.



All cash is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits.
Generally, these deposits may be redeemed upon demand and, therefore, bear minimal risk. The Company has a self-imposed a restriction on $67,000 of cash for product production.



Inventory is stated at the lower of cost, determined by the first-in, first-out method, or market. Market is determined based on the net
realizable value, with appropriate consideration given to obsolescence, excessive levels, deterioration and other factors.



Trade accounts receivable consist primarily of receivables from the sale of water filtration devices. The Company sells to its customers based on its standard credit
policies and regularly reviews accounts receivable for any bad debts. The review for bad debts is based on an analysis of the Companys collection experience, customer credit worthiness, and current economic trends. Based on managements
review of accounts receivable, no allowance for doubtful accounts is considered necessary at June 30, 2004.



The Company also reviews other receivables for any bad debts and has determined that an allowance of $20,000 is adequate as of June 30, 2004



Property and equipment are recorded at cost. Depreciation is calculated by the straight-line method over the estimated useful lives of the
assets, ranging generally from 2 to 10 years. Additions to and major improvements of property and equipment are capitalized. Repair and maintenance expenditures are charged to expense as incurred. As property or equipment is sold or retired, the
applicable cost and accumulated depreciation are eliminated from the accounts and any gain or loss is recorded. Depreciation expense amounted to approximately $27,400 and $33,600 for the years ended June 30, 2004 and 2003, respectively.



The Company has adopted Statement of Financial Accounting Standards Board No. 144 (SFAS
No. 144), Accounting for the Impairment or Disposal of Long-Lived Assets. SFAS No. 144 addresses the financial accounting and reporting for the impairment of long-lived assets, excluding goodwill and intangible assets, to be held and
used or disposed of. The adoption of SFAS No. 144 did not have an impact on the Companys financial position or results of operations. In accordance with SFAS No. 144, the carrying values of long-lived assets are periodically reviewed by the
Company and impairments would be recognized if the expected future operating non-discounted cash flows derived from an asset were less than its carrying value and if the carrying value is more than the fair value of the asset. As of June 30, 2004,
the Company did not have any asset that it considered to be impaired.



F-9



---

##### Table of Contents

Innova Pure Water, Inc.



Notes to Financial Statements



Years Ended June 30, 2004 and 2003



3. Significant Accounting Policies (continued)



Intangible assets that are included in other assets in the accompanying financial statements are being amortized over their estimated useful
life of five years. Amortization recognized during the years ended June 30, 2004 and 2003 amounted to $92,100 and $110,300, respectively.



Amortization expense for the next five years is estimated as follows:



|     |  |   |       
|---- |  | - | ------
|2005 |  | $ | 79,000
|2006 |  |   | 56,000
|2007 |  |   | 29,000
|2008 |  |   | 22,000
|2009 |  |   | 19,000



The Company recognizes revenue at the
time products are shipped. Any deposits received in advance of product shipment are reflected as liabilities until the products are shipped.



Research and development costs are charged to operations when incurred and are included in operating expenses. The amounts charged for the years ended June 30, 2004 and
2003 amounted to $10,100 and $92,300, respectively.



Fair value estimates
discussed herein are based upon certain market assumptions and pertinent information available to management. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values.



These financial instruments include cash, accounts receivable, accounts payable, and accrued
expenses. Fair values were assumed to approximate carrying values for these financial instruments since they are short-term in nature and their carrying amounts approximate fair values or they are receivable or payable on demand. The fair value of
the Companys notes payable is estimated based upon the quoted market prices for the same or similar issues or on the current rates offered to the Company for debt of the same remaining maturities.



The Company records shares of common stock as outstanding at the time the Company
becomes contractually obligated to issue shares. As of June 30, 2004, the Company has 12,423,601 shares outstanding.



Costs of discounts and point-of-sale rebates are recognized at the date at which the related sales revenue is recognized and are recorded as a reduction of
sales revenue. The Company does not currently offer any discounts or point-of-sale rebates to its customers.



Basic loss per share is calculated by dividing net loss by the average number of common shares outstanding during the year. Diluted loss per common share is calculated by adjusting outstanding shares, assuming
conversion of all potentially dilutive stock options. At June 30, 2004 and 2003, there were no dilutive instruments outstanding.



F-10



---

##### Table of Contents

Innova Pure Water, Inc.



Notes to Financial Statements



Years Ended June 30, 2004 and 2003



3. Significant Accounting Policies (continued)



Financial Accounting Standards Board Statement 123 (FASB 123), Accounting for Stock-Based Compensation, provides that expense equal to the fair value of
all stock-based awards on the date of the grant be recognized over the vesting period. Alternatively, this statement allows entities to continue to apply the provisions of Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock
Issued to Employees, whereby compensation expense is recorded on the date the options are granted equal to the excess of the market price of the underlying stock over the exercise price. The Company has elected to continue to apply the
provisions of APB



FASB issued SFAS No. 148, Accounting for Stock-Based
Compensation  Transition and Disclosure, which is effective for the Company as of January 1, 2003. This statement amends SFAS No. 123, Accounting for Stock-Based Compensation, to provide alternative methods of transition for
a voluntary change to the fair value based method of accounting for stock-based employee compensation. In addition, this statement amends the disclosure requirements of SFAS No. 123 to require prominent disclosures in both annual and interim
financial statements about the method of accounting for stock-based employee compensation and the effect of the method used on reported results.



Pro forma information regarding net income and net income per share is required by SFAS No. 123, and has been determined as if the Company had accounted for its stock
options under the fair value method of SFAS No. 123. The fair value of each option grant is estimated on the date of grant using the Black-Scholes option valuation model. During fiscal year ended June 30, 2004, no options were granted. The following
table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of SFAS No 123, to stock-based employee compensation.



|                                        |  |      |          |   |      |   |          |  
|--------------------------------------- |  | ---- | -------- | - | ---- | - | -------- | -
|                                        |  | 2004 |          |   | 2003 |  
|As reported:                            |  |      |          |   |      |   |          |  
|Net loss                                |  | $    | (282,800 | ) |      | $ | (579,700 | )
|                                        |  |      |          |   |      |   |          |  
|Basic and diluted loss per common share |  | $    | (.02     | ) |      | $ | (.05     | )
|                                        |  |      |          |   |      |   |          |  
|Pro forma:                              |  |      |          |   |      |   |          |  
|Net loss                                |  | $    | (282,800 | ) |      | $ | (799,800 | )
|                                        |  |      |          |   |      |   |          |  
|Basic and diluted loss per common share |  | $    | (.02     | ) |      | $ | (.07     | )
|                                        |  |      |          |   |      |   |          |  



F-11



---

##### Table of Contents

Innova Pure Water, Inc.



Notes to Financial Statements



Years Ended June 30, 2004 and 2003



4. Inventories



Inventories consist of raw materials valued at $19,500.



5. Property and Equipment



Property and equipment consist of:



|                         |  |   |        
|------------------------ |  | - | -------
|Tooling                  |  | $ | 160,100
|Machinery and equipment  |  |   | 136,000
|                         |  |   |        
|                         |  | $ | 296,100
|Less:                    |  |   |        
|Accumulated depreciation |  |   | 280,900
|                         |  |   |        
|                         |  | $ | 15,200 
|                         |  |   |        



6.
Related Party Transactions and Commitments



During the year ended June 30,
2003, the Company had an employment agreement with its President who is also the Chief Executive Officer. This agreement as extended lapsed on June 30, 2003 and was not renewed. The Company continued to provide compensation in the amount of $82,500
for the year ended June 30, 2004 for services rendered. In accordance with the terms of the 2003 agreement, this officer was due $150,000 in compensation per year, however, she agreed to a reduction in her compensation to $110,000 per year. In
addition, during 2003 she has received 742,763 shares of stock in lieu of cash payments of $51,100. The agreement also entitled this officer to receive commissions of two percent of adjusted net sales of the Company, for the year ended June 30,
2002, which totaled approximately $11,600. On October 9, 2002, this officer was granted 1,250,000 stock options by the Board of Directors, which are exercisable over the next 10 years at a price of $.12 a share. These options were granted to her for
her continuing service and loyalty to the Company as well as her agreeing to a reduction in her annual salary and debt forgiveness in prior years. The balance due her under the employment agreements as of June 30, 2004 amounted to $223,700.



During the year ended June 30, 2003, the Company also had an agreement with
its Chairman of the Board of Directors. This agreement as extended lapsed on June 30, 2003 and was not renewed. The Company accrued $82,500 during 2004 to the Chairman for services rendered. In accordance with the terms of the 2003 agreement, this
director is to receive payments based on sales of certain products with a minimum of $110,000 per year. The total amount incurred under this arrangement was $110,000 for the year ended June 30, 2003. On October 9, 2002, this officer was granted
1,270,000 options by the Board of Directors, which are exercisable over the next 10 years at a price of $.12 a share. These options were granted to him for his continuing service and loyalty to the Company as well as his agreeing to defer some of
the payments that were due him and debt forgiveness in prior years. In addition, during 2003 he received 762,544 shares of stock in satisfaction of $55,600 of amounts due him. The net balance due this director under the agreement as of June 30, 2004
amounted to $93,900.



F-12



---

##### Table of Contents

Innova Pure Water, Inc.



Notes to Financial Statements



Years Ended June 30, 2004 and 2003



6. Related Party Transactions and Commitments (continued)



The above agreements are not necessarily indicative of the agreements that would have been entered into by independent parties.



7. Note Payable



On March 26, 2002, the Company received proceeds of $400,000 in exchange for a note payable.
The note payable is payable in five years at zero percent interest and is unsecured. In connection with the payable, the Company issued 1,200,000 stock options valued at $180,000 using the Black Scholes method, and is recorded as a discount on the
note payable. During the year ended June 30, 2004, the Company entered into an agreement to issue a non-exclusive right to a patent in satisfaction of $200,000 of the note payable and cancellation of 800,000 common stock options. As a result of the
cancellation of options, the unused value of these options was charged against additional paid in capital. For the year ended June 30, 2004 and 2003, the Company amortized $12,200 and $45,000 of the discount to interest expense, respectively.



8. Lease Commitments



The Company rents its operating facilities under a non-cancelable operating lease expiring
in 2005.



The following is a schedule by year of future minimum rental payments
required under these leases as of June 30, 2004:



|                     |  |   |       
|-------------------- |  | - | ------
|Year Ending June 30, |  |  
|2005                 |  | $ | 31,300



Rent expense amounted to approximately
$40,600 and $54,400 for the years ended June 30, 2004 and 2003, respectively.



The Company is also a guarantor on an automobile leased by the Chairman of the Board which expires in April 2007 and has $23,800 payments remaining as of June 30, 2004.



9. Income Taxes



The Company has incurred significant operating losses since its inception that have been carried forward for income tax purposes and, therefore, no tax liabilities
have been incurred for the years presented. These operating losses and other timing differences give rise to a deferred tax asset and are as follows:



F-13



---

##### Table of Contents

Innova Pure Water, Inc.



Notes to Financial Statements



Years Ended June 30, 2004 and 2003



9. Income Taxes (continued)



|                         |  |      |            |  
|------------------------ |  | ---- | ---------- | -
|                         |  | 2004 |           
|Deferred tax asset:      |  |      |            |  
|Deferred compensation    |  | $    | 127,000    |  
|Stock based compensation |  |      | 43,500     |  
|Amortization             |  |      | 137,000    |  
|Deferred revenue         |  |      | 80,000     |  
|Other timing differences |  |      | 111,500    |  
|Loss carryforward        |  |      | 1,815,000  |  
|                         |  |      |            |  
|Net deferred tax asset   |  |      | 2,214,000  |  
|Allowance                |  |      | (2,214,000 | )
|                         |  |      |            |  
|                         |  | $    |           |  
|                         |  |      |            |  



Differences between the federal
benefit computed at a statutory rate and the Companys effective tax rate and provision are as follows:



|                                                    |  |      |         |   |      |   |          |  
|--------------------------------------------------- |  | ---- | ------- | - | ---- | - | -------- | -
|                                                    |  | 2004 |         |   | 2003 |  
|Statutory benefit                                   |  | $    | (99,000 | ) |      | $ | (197,000 | )
|State tax benefit, net of federal effect            |  |      | (16,000 | ) |      |   | (7,000   | )
|Officers Life Insurance                             |  |      | 7,000   |   |      |   | 11,000   |  
|Non-deductible expenses                             |  |      | 2,000   |   |      |   |          |  
|Increase in deferred income tax valuation allowance |  |      | 106,000 |   |      |   | 193,000  |  
|                                                    |  |      |         |   |      |   |          |  
|                                                    |  | $    |        |   |      | $ |         |  
|                                                    |  |      |         |   |      |   |          |  



The Company has available at June 30,
2004 approximately $5 million of unused operating loss carryforwards that may be applied against future taxable income, which would reduce taxes payable by approximately $1.8 million in the future. These operating loss carryforwards began expiring
June 30, 2004. Income tax benefits resulting from the utilization of these carryforwards will be recognized in the year in which they are realized for federal and state tax purposes. Approximately $220,000 of the unused net operating loss
carryforwards expired in the fiscal year ended June 30, 2004.



The Company has
provided a full valuation allowance related to the realizability of the deferred tax asset. The valuation allowance is based on evidence that the deferred tax asset will more likely than not, not be realized. Such valuation allowance may be
increased or decreased in the future based on the likelihood of achieving future taxable earnings.



10. Preferred Stock



Effective October 24, 1996, the Board of Directors authorized 2,000,000 shares of preferred stock with a par value of $.001 per share. The Board of Directors is
authorized to issue the preferred stock in series and to fix, in the manner and to the full extent provided and permitted by law, the rights, preferences, and limitations of each series of preferred stock. At June 30, 2004, there were no shares of
preferred stock issued or outstanding.



F-14



---

##### Table of Contents

Innova Pure Water, Inc.



Notes to Financial Statements



Years Ended June 30, 2004 and 2003



11. Stock Options and Warrants



On April 22, 1999, the Company adopted the 1999 Stock Option Plan. Under the plan, options to issue up to 1,000,000 shares of the Companys common stock
may be granted. The option price shall not be less than the greater of $.50 per share or 100 percent of the fair market value of the underlying common stock on the date of grant. As of June 30, 2004, 100,000 options were outstanding under the plan
at $.50 per share. These options expire in 2009.



During the year ended June
30, 2002, the Companys 1999 Stock Option Plan was amended to allow the remaining options to be granted at an option price not less than the greater of $.25 per share or 100 percent of the fair market value of the underlying stock on the date
of the grant. During the year ended June 30, 2002, an additional 755,000 stock options at $.25 per share were granted under the 1999 Stock Option Plan. At June 30, 2004, 660,000 of these options are outstanding, fully vested and exercisable anytime
through August 31, 2006, and 65,000 and 30,000 options were forfeited during 2004 and 2003, respectively. Under APB No. 25, no expense was recognized.



During the years ended June 30, 2004 and 2003, none of the options granted under the 1999 Stock Option Plan had been exercised.



On March 26, 2002, the Company entered into an agreement with an individual to provide
marketing activities to the Company. In exchange for these services, this individual was granted 1.2 million options, which was subsequently reduced to 400,000 options, as compensation. These options are immediately exercisable, expire in five
years, with the following terms:



200,000 warrants may be
converted into 200,000 shares of Innova stock at $.50



200,000
warrants may be converted into 200,000 shares of Innova stock at $.75



As of
June 30, 2004, none of these options has been exercised.



During the year
ended, June 30, 2004, the Company recognized that the issuance of these options was partially based upon the relationship between the individual and the entity that advanced the Company $400,000 on an interest-free loan and will no longer consider
the individual an employee. Therefore, the Company has treated the fair value of these options, $180,000, as prepaid interest to be amortized over the term of the note. During the year ended June 30, 2004, the Company entered into an agreement to
issue a non-exclusive right to a patent in satisfaction of $200,000 of the note payable and cancellation of 800,000 common stock options. As a result of the cancellation of options, the unused value of these options and the related discount of
$87,200 was charged against additional paid in capital.



During the year ended
June 30, 2004, the Company did not issue any options. During the year ended June 30, 2003, the Company issued 2,520,000 options exercisable over 10 years, to two officers of the Company at an exercise price of $.12 per share. Under APB No. 25,
no compensation expense was recognized in connection with these options as the fair market value of the stock was less than the exercise price.



F-15



---

##### Table of Contents

Innova Pure Water, Inc.



Notes to Financial Statements



Years Ended June 30, 2004 and 2003



11. Stock Options and Warrants (continued)



The Company grants options to various individuals to purchase the Companys common stock at the discretion of the Board of Directors. During the year ended June 30,
2002, the Company reissued 150,000 stock options to certain individuals in order to extend their expiration dates. These options are still exercisable at $.50 per share and their new expiration dates range from June 2003 through June 2004. Under
SFAS No 123, no expense has been recognized in connection with these options.



The following is a summary of stock option activity during 2004 and 2003:



|                                               |  |                         |   |  |                              |      |   |                  |            |   |                              |   |      |  
|---------------------------------------------- |  | ----------------------- | - |  | ---------------------------- | ---- | - | ---------------- | ---------- | - | ---------------------------- | - | ---- | -
|                                               |  | 1999 Stock Option Plans |   |  | Other                        |     
|                                               |  | Numberof Shares         |   |  | WeightedAverageExercisePrice |      |   | Number of Shares |            |   | WeightedAverageExercisePrice |  
|Options granted and outstanding, June 30, 2002 |  | 855,000                 |   |  | $                            | .28  |   |                  | 1,600,000  |   |                              | $ | .69  |  
|Options granted during the year                |  |                         |   |  |                              | .25  |   |                  | 2,520,000  |   |                              |   | .12  |  
|Options forfeited during the year              |  | (30,000                 | ) |  |                              | (.25 | ) |                  | (100,000   | ) |                              |   | (.50 | )
|                                               |  |                         |   |  |                              |      |   |                  |            |   |                              |   |      |  
|Options granted and outstanding, June 30, 2003 |  | 825,000                 |   |  | $                            | .28  |   |                  | 4,020,000  |   |                              | $ | .34  |  
|Options forfeited during the year              |  | (65,000                 | ) |  |                              | (.25 | ) |                  | (1,100,000 | ) |                              |   | (.73 | )
|                                               |  |                         |   |  |                              |      |   |                  |            |   |                              |   |      |  
|Options granted and outstanding, June 30, 2004 |  | 760,000                 |   |  | $                            | .28  |   |                  | 2,920,000  |   |                              | $ | .19  |  
|                                               |  |                         |   |  |                              |      |   |                  |            |   |                              |   |      |  



The following table summarizes the
status of options outstanding at June 30, 2004:



|                       |  |                     |     |                     |           |                                         |            |        |           |                                         |           
|---------------------- |  | ------------------- | --- | ------------------- | --------- | --------------------------------------- | ---------- | ------ | --------- | --------------------------------------- | ----------
|                       |  | Outstanding Options |     | Exercisable Options
|                       |  | ExercisePrice       |     | Number              |           | WeightedAverageRemainingContractualLife |            | Number |           | WeightedAverageRemainingContractualLife
|1999 Stock Option Plan |  | $                   | .25 |                     | 660,000   |                                         | 2.17 years |        | 660,000   |                                         | 2.17 years
|Other Options          |  | $                   | .50 |                     | 200,000   |                                         | 2.74 years |        | 200,000   |                                         | 2.74 years
|Other Options          |  | $                   | .75 |                     | 200,000   |                                         | 2.74 years |        | 200,000   |                                         | 2.74 years
|1999 Stock Option Plan |  | $                   | .50 |                     | 100,000   |                                         | 4.75 years |        | 100,000   |                                         | 4.75 years
|Other Options          |  | $                   | .12 |                     | 2,520,000 |                                         | 8.28 years |        | 2,520,000 |                                         | 8.28 years



F-16



---

##### Table of Contents

Innova Pure Water, Inc.



Notes to Financial Statements



Years Ended June 30, 2004 and 2003



11. Stock Options and Warrants (continued)



The Company estimates the fair value of each stock option at the grant date by using the Black-Scholes option-pricing model with the following assumptions:



|                                                          |  |      |          |  
|--------------------------------------------------------- |  | ---- | -------- | -
|                                                          |  | 2003 |         
|Risk free interest rate                                   |  |      | 3.60     |  
|Expected years until exercise                             |  |      | 10 years |  
|Expected dividend yield                                   |  |      | 0.00     | %
|Estimated fair market value of underlying stock per share |  | $    | .09      |  



In addition to the above, the Company
had outstanding at June 30, 2001 warrants to purchase 250,000 shares of the Companys common stock at a price of $.50 per share. The warrants were exercisable at any time through August 18, 2001, at which time the warrants expired. During the
year ended June 30, 2002, the Company extended the term by two years on these warrants. No expense was recognized with the extension of these warrants. As of June 30, 2004, these warrants expired.



12. Royalties and Other Income



Royalty and other income for the years ended June 30, 2004 and 2003 are $134,600 and
$70,100, respectively. These amounts are the result of royalties received from the licensing of the Companys technology to Brita Products and Seychelle Environmental Technologies and from licensing fees paid by CamelBak and Sawyer Products.



13. Legal Settlements and Contingencies



The Company is currently the plaintiff in a patent infringement lawsuit
entitled Innova/Pure Water, Inc., Plaintiff v. Safari Water Filtration Systems, Inc. d/b/a Safari Outdoor Products, Defendant; Case No. 99-1781-Civ-T-23F filed by the Company on August 4, 1999. The case was filed with the U.S. District Court, Middle
District of Florida, Tampa Division. The Company has claimed patent infringement of U.S. Patent 5,609,759 on the part of the defendants. On December 16, 2003, the court ruled in favor of Safari. Innova filed an appeal with the United States Court of
Appeals, case No. 04-1097, who, on August 11, 2004, reversed the lower courts decision. The case has been remanded back to the Circuit Court on September 1, 2004 to find on any remaining issues. Innova has filed for a summary judgment or the prompt
setting of a trial date. It is not yet possible to evaluate the likelihood of a favorable or unfavorable outcome.



F-17